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GENERAL INTRODUCTION 
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Definition 
The thoracic aorta is divided into 4 parts: the aortic root (which includes the aortic 
valve annulus, the aortic valve leaflets, and the sinuses of Valsalva); the ascending 
aorta (which includes the tubular portion of the ascending aorta beginning at the 
sinotubular junction and extending to the origin of the brachiocephalic artery); the 
aortic arch (which begins at the proximal part of the origin of the brachiocephalic 
artery and ends at the distal part of the origin of the left subclavian artery; the arch 
is the origin of the head and neck arteries, coursing in front of the trachea and to the 
left of the oesophagus and the trachea); and the descending aorta (which begins at 
the isthmus between the origin of the left subclavian artery and the ligamentum 
arteriosum and courses anterior to the vertebral column, and then through the 
diaphragm into the abdomen) [1]. The proximal thoracic aorta includes the aortic 
root, the ascending aorta and the aortic arch. 
Surgery of the proximal thoracic aorta: results and causes of reoperation 
Over the last decades, outcomes of aortic surgery have continuously improved. 
Consolidated strategies and new surgical techniques have increased patients’ chance 
of survival and allowed more complex aortic procedures. The well-documented 
development in aortic arch surgery and cerebral protection techniques and the spread 
of aortic root replacement, lead surgeons to be more aggressive towards extensive 
aortic procedures both in elective and emergency settings.  
The results are outstanding. Contemporary experiences reported an average 30-day 
mortality of 3% [2][3] for patients undergoing aortic root replacement; the Bentall 
procedure and its modification are nowadays widely accepted and extensively 
performed and represent the golden standard for aortic root repair. Aortic valve-
sparing procedures have shown to be safe and effective in the treatment of root 
aneurysm in presence of normal aortic valve leaflets [4][5]; more data and longer 
follow-up are needed to confirm similar excellent results in sparing bicuspid aortic 
valves or in presence of leaflets abnormalities. 
Recent papers with large study populations reported acceptable mortality and risk 
of cerebrovascular accidents in patients undergoing aortic arch replacement. 
Antegrade selective bilateral cerebral perfusion and systemic hypothermic 
circulatory arrest represent the cornerstone of cerebral, spinal cord and visceral 
protection. This strategy guarantees a safe time window for performing complex and 
time-consuming surgery minimizing the risk of cerebral injuries. 
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New hybrid procedures have been proposed in the treatment of arch aneurysms. 
These techniques conjugate standard approaches (in most of the cases sternotomy 
and cardiopulmonary bypass are needed) and endovascular solutions to achieve the 
complete exclusion of arch aneurysms and restore the physiologic cerebral 
perfusion. However, stating the limited availability of data and lack of long-term 
follow-up, at this stage, these procedures should be reserved only to high risk and 
elderly patients. 
Despite well-established results in the treatment of chronic aortic pathologies, acute 
aortic dissection repair is still burdened by high mortality and morbidity rates. This 
is related to the acute systemic involvement besides the frailty and disruption of the 
vascular tissue. The primary goal in treating patients with acute type A aortic 
dissection is the survival of the patient by preventing aortic rupture and cardiac 
tamponade, restoring normal aortic valve function and solving malperfusion 
syndromes. The basic protocol in acute dissection repair, which has shown to be 
safe and effective, provides excision of the main intimal tear with supracoronary 
ascending aortic replacement and reapproximation of the aortic layers. The approach 
with an open distal anastomosis allows a better exposure, a more extensive aortic 
excision and a safer handling of fragile tissue. More radical primary procedures, 
addressing to systematic root replacement or arch replacement, are extremely 
fascinating in ‘’freezing’’ this disease aiming for a better outcome and a better 
freedom from reoperation, however, this aggressive approach could result in a 
higher rate of disabling postoperative complications. Adjunctive root replacement 
and arch surgery should be reserved in presence of a more proximal or distal intimal 
tear or in case of severe aortic wall disruption or important dilatation of these aortic 
segments.  
A more extensive repair for the treatment of chronic aneurysm or acute dissection 
can minimize the risk of new aortic procedures but the progression of the disease in 
untreated aortic segments or the occurrence of aortic complications may leave many 
patients at risk for future reoperations. 
The causes leading to aortic reoperations can be categorised as: 
• Progression of aortic diseases: the combination of several mechanical, 
clinical, genetic and metabolic factors [6][7] concur to determine the 
evolution of residual dissected or pathological aortic wall, new aneurysms 
may also arise from previously apparently healthy aortic tissue;  
• Complications: unpredictable and life-threatening complications, such as 
endocarditis and false aneurysm, may require additional surgical procedures;  
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• Pathologic evolution of implanted prosthesis: the progressive degeneration 
of an implanted biologic valve conduit, pulmonary autograft or an aortic 
homograft could address many patients to a reoperation that is usually 
perceived as challenging and very risky. 
An operative mortality rate up to 18% has been previously reported after proximal 
aortic reoperations [8][9][10][11]. The interpretation of these studies is limited 
because of the great variability in patients’ selection criteria and differences in initial 
cardiac/aortic procedure and subsequent reoperations [8][9][12]. However, an 
important message came from these experiences: pathologic evolution of unresected 
aorta and aortic complications are not uncommon, they may occur several years after 
the primary aortic repair and should be suspected in presence of persistent 
infection/inflammation signs, onset of new inexplicable dyspnoea or mass-effect 
symptoms. Therefore, the suggestion for a routine clinical and imaging follow-up 
that is mandatory also in asymptomatic patients to detect aortic lesions with 
unpredictable evolution, which could convey patients to emergency and high-risk 
surgery. 
Reoperation on the Aortic Root and the Ascending Aorta: preoperative 
evaluation and management 
The first goal in aortic reoperation is to achieve a safe chest re-entry and to manage 
catastrophic blood loss in case of damage of cardiac and vascular structures during 
resternotomy. A preoperative CT scan evaluation is mandatory. Several strategies 
have been proposed in previous reports according to the relationship between 
mediastinal structures and the posterior aspect of the sternum. Peripheral 
cardiopulmonary bypass institution before re-entry should be performed in case of 
cardiac and vascular structures strictly adherent to the chest wall. The lower tension 
in the empty heart and mediastinal vessels may reduce the possibility of injury. 
Furthermore, CPB guarantees full assistance in case of hemodynamic imbalance and 
allows systemic cooling for hypothermic circulatory arrest. Further techniques have 
been proposed to achieve a safer cerebral and cardiac protection. Some authors 
suggested the extra-anatomic cannulation of cerebrovascular vessels (i.e. carotid 
arteries, right subclavian artery) in presence of a giant mediastinal aneurysm or a 
false aneurysm. The anatomy of these lesions could not permit, especially in case of 
complications during the chest re-entry, an adequate cerebral protection by femoral 
vessel perfusion or in case of difficult or impossible selective cannulation of the 
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epiaortic vessels from the inner side of the aortic arch [13]. The occurrence of left 
ventricular distension during re-entry can cause severe myocardial dysfunction at 
the end of the operation. This complication should be taken into account in patients 
with severe aortic regurgitation. In these cases, a slow systemic cooling may avoid 
ventricular fibrillation and the distension of the left ventricle. If the ascending aorta 
cannot be controlled and cross-clamped in a short time, a transapical intraventricular 
vent cannula should be placed from a small left anterior thoracotomy [14][15]. 
Myocardial protection is an independent risk factor for the early outcome and is 
therefore crucial. Usage of retrograde cardioplegia [16], antegrade cold crystalloid 
cardioplegia or continuous antegrade cold blood cardioplegia delivered by a soft 
cannula inserted in the coronary ostia [17], are useful tools to overcome the risk for 
insufficient cardioprotection. Cardiac ischemia may also occur, especially in root 
procedures, during CPB weaning and in the early postoperative setting secondary to 
an inadequate coronary flow re-establishment. Handling fragile or calcified 
coronary ostia is demanding. Failure in coronary reimplantation and unplanned 
CABG were reported in up to 25-50% of the cases [8][17][18] and represent a 
significant risk factor for mortality [8]. 
Extensive and more radical surgery should be preferred during the reoperation in 
order to minimize the need for further procedures. Valve prosthesis choice is related 
to patients’ characteristic, age and co-morbidities. Biologic prostheses have a 
satisfactory durability in patients aged more than 65 years. Mechanical prostheses 
are the first option in younger patients. In aortic position they required a low degree 
of anticoagulation and showed acceptable rate of embolic events per year and a 
resistance to endocarditis comparable to biological prostheses [19][20]. 
Reoperations for endocarditis are more risky especially when complicated by 
annular and periannular involvement. Extensive debridement and removal of 
prosthetic device and infected and frail tissue is mandatory but a faster operation 
could be the only valid life-saving procedure in severely ill patients. 
The possibility to avoid an open surgical procedure is attractive especially in 
patients presenting with critical preoperative status. In recent years percutaneous 
stent graft placement, device occluder implantation and coil embolization have been 
proposed for the treatment of false aneurysms of the thoracic aorta [21] or to close 
paravalvular leaks [22], despite these advances in transcatheter procedures open 
conventional surgery is still the most safe and effective approach in these settings. 
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Aim and outline of the thesis 
Reoperations on the thoracic aorta represent a great challenge for cardiovascular 
surgeons. Several preoperative and intraoperative variables can influence patients’ 
outcome. Different types of previous operation, underlying comorbidities, aortic 
wall pathologies and etiologic factors and the adoption of various surgical strategies 
in the redo setting, account for a highly heterogeneous population with inherent 
difficulties and limitations for a systematic study and analysis. 
We were able to evaluate more homogenous cohorts of patients and in this thesis we 
propose the results of our experience in reoperation of the proximal aorta. We 
characterized the presentation, the surgical management and the operative results of 
our populations. The aim of this study was the evaluation of: 
  
• Clinical outcomes after aortic reoperations; 
• Causes leading to a reoperation of the proximal thoracic aorta; 
• Factors suggesting a possible complicated or suboptimal course after the 
primary repair; 
• Surgical strategies for a safe reoperation and reduced risk of further 
complications; 
• Role of conventional surgical procedures in the era of evolving less-invasive 
strategies.  
We present our studies in three sections (Part 1 – 3). 
Part 1 – Post surgical Aortic False Aneurysm (Chapters 2 – 4) 
Aortic False Aneurysm is a rare complication after aortic surgery, its occurrence has 
been reported in 0.5-1% of the cases after cardiac surgery. However, the initial 
usually silent course and the study limited to surgical series could account for the 
underestimation of its incidence. In the Chapters 2 – 4 we present the results of our 
experiences on post surgical Aortic False Aneurysm including the evaluation of 
pathogenetic factors, clinical and anatomical presentation, surgical strategies and 
outcomes. 
Chapter 2: reviews the St. Antonius Ziekenhuis experience in the surgical treatment 
of post surgical aortic false aneurysms. 
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Chapter 3: reports a technical failure with an unusual spontaneous rupture of a 
polypropylene suture leading to the development of a proximal false aneurysm after 
a composite valve graft root replacement. 
Chapter 4: reviews the Istituto Clinico Humanitas experience in the treatment of 
post surgical aortic false aneurysm with a closer view to infective etiology and 
presents the outcome of patients who underwent a conservative medical 
management. 
Part 2 – Reoperations on the Aortic Root (Chapters 5 – 6) 
Aortic Root reoperations are still perceived as extremely challenging and high risk 
for the patients. Several factors account for different scenarios of a redo operation 
on the Aortic Root. In Chapters 5 and 6, we evaluated the causes of redo procedures 
and proposed our strategies to achieve a safe reoperation.  
Chapter 5: this paper, at the time of its publication, represented the largest series of 
“true” re-root procedures. This chapter investigates preoperative and perioperative 
determinants of patients’ outcome in redo root procedures focusing on successful 
myocardial protection and physiological coronary flow re-establishment. 
Chapter 6: describes the results of reoperations on homografts and pulmonary 
autografts. In these young patients a redo surgical procedure is encountered as very 
challenging and high risky.  
Part 3 – Reoperations after dissection repair (Chapters 7) 
Acute Aortic Dissection is a life-threatening complication and its management is 
still burdened by high mortality and morbidity rate. The surgical repair is the only 
life-saving procedure for type A Acute Aortic Dissection, a postoperative mortality 
rate around 20% is still reported in large case series but if left untreated this 
condition is associated with a mortality higher than 90% in the short term. Around 
20% to 30% of the patients who survived the primary repair can undergo a 
reoperation. We explore the causes for a redo procedure, the possible factors 
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predicting the needs for further operations and the outcomes of these complex 
surgical procedures. 
Chapter 7: represents the largest series of reoperation after acute type A dissection 
repair. We investigated the role of prior surgical strategies and the specific aortic 
segments’ involvement in determining the causes, sites and types of reoperation. 
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PART 1  
POST SURGICAL AORTIC FALSE ANEURYSM
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CHAPTER 2 
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Abstract 
Background. Aortic false aneurysm is a rare complication after cardiac surgery. 
Aortic dissection, infection, arterial wall degeneration, and poor surgical technique 
are recognized as risk factors for the occurrence of postsurgical false aneurysm. 
Despite some recent reports about percutaneous false aneurysm exclusion, a 
complex surgical reoperation is needed in most of the cases. 
Methods. We retrospectively reviewed our experience in 43 patients who received 
a reoperation for postsurgical aortic false aneurysm in the last 14 years. Thirty-three 
patients were male. The mean age was 60 ± 12 years. Most of the patients received 
prior aortic surgery on the aortic root, the ascending aorta, the aortic arch, and the 
descending thoracic aorta (38 patients). False aneurysm was diagnosed during 
follow-up evaluation in the absence of any symptoms in 23 cases. Univariate and 
multivariate analyses on 18 perioperative variables were performed. 
Results. In-hospital mortality was 6.9% (3 patients). The postoperative course was 
complicated in 17 cases (39%). At multivariate analysis, a preoperative history of 
coronary artery disease and postoperative sepsis were independent risk factors for 
hospital mortality. Survival rates at 1, 5, and 10 years were 94%, 79%, and 68%, 
respectively. Freedom from reoperation was 86% at 1 year and 72% at 5 and 10 
years.
Conclusions. Despite a high postoperative complication rate, a reoperation for 
postsurgical aortic false aneurysm can be performed with acceptable mortality and 
good mid-term and long-term outcomes. 
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Aortic false aneurysms are a rare complication after thoracic aortic surgery [1]. They 
are the result of the disruption of at least one layer of the vessel wall at the 
cannulation site or along the aortic suture lines. Initially, the aortic false aneurysm 
is surrounded and controlled by the remaining vascular layers or closely related 
structures of the mediastinum with or without development of a neointima. When 
the pressure of the aortic false aneurysm exceeds the maximally tolerated wall 
tension of the surrounding tissue, fatal rupture occurs, usually into the pleural cavity. 
Other life-threatening complications such as a bleeding fistula, compression, or 
erosion of the surrounding structures are also the result of the progressive increase 
of the size of the aortic false aneurysm.  
Graft infection and mediastinitis, progressive aortic wall disease, dissection of the 
native aorta, and excessive use of biologic glue [2, 3] are recognized as etiologic 
factors for the development of a false aneurysm. The clinical presentation of a false 
aneurysms of the thoracic aorta is either acute as a result of a usually life-threatening 
complication or subacute during planned follow-up, although persistent infection 
and systemic embolization are also described as clinical presentations [4]. 
Despite some advances in endovascular techniques [5, 6], the treatment in most of 
the cases remains surgical and varies according to the site and the morphology of 
the false aneurysm. Reoperations are challenging and affected by a high mortality 
and morbidity rate [1, 7, 8]. We aim to present our experience in 43 consecutive 
patients who underwent a reoperation for postsurgical false aneurysm of the thoracic 
aorta. 
Patients and Methods 
Patient Population 
Between January 1995 and October 2009, 43 consecutive patients underwent a 
reoperation for false aneurysm involving the thoracic aorta from the aortic root to 
the distal arch. The ethics committee of the St. Antonius Hospital, Nieuwegein, the 
Netherlands, approved the study and waived the need for patient consent. The mean 
age of the patients at the time of reoperation was 60 ± 12 years (range, 31 to 80 
years), and 33 (77%) were male. The mean interval between the previous procedure 
and the actual operation was 8 years (range, 0.20 to 37.1 years). An emergency 
operation was required in 9 patients. Seven patients had preoperative coronary artery 
disease characterized by angiographic evidence of significant (>50%) coronary 
stenosis or by a previous history of myocardial revascularization (coronary artery 
bypass grafting or percutaneous coronary intervention). The mean follow-up was 48 
± 51 months. The patient characteristics are shown in Table 1. 
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Prior Operation Performed 
The type of the previous 
operation (the most recent in 
case of several previous 
operations) and concomitant 
procedures performed are 
listed in Table 2. Most of the 
patients had a replacement or 
repair of the aortic root (26 
patients, 60%) and a 
replacement of the ascending 
aorta (14 patients, 32%).  
Indication for Reoperation 
and Surgical Techniques
The presence of an aortic 
false aneurysm was the main 
indication for reoperation in all the cases. Four patients presented with a native or 
prosthetic aortic valve dysfunction. Table 3 describes the actual operative 
procedures performed. The technique for replacement of the aortic root, ascending 
aorta, aortic arch, and 
descending aorta has been 
described previously [9 –
11]. Briefly, a median 
sternotomy was performed 
in 40 patients; in 3 patients, 
who underwent thoracic 
descending (n = 2) and 
thoracoabdominal (n = 1) 
aorta replacement, a 
posterolateral thoracotomy 
in the fifth or sixth 
intercostal space 
(extending in a median 
laparotomy in case of 
thoracoabdominal aortic 
aneurysm) was performed. 
Usually, cardiopulmonary 
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bypass (CPB) was instituted using 
the common femoral artery (56%), 
the ascending aorta or aortic arch 
(20%), or subclavian artery (14%) 
as the arterial inflow site and the 
right atrium (directly or through 
the femoral vein using a double-
staged cannula) for venous 
drainage. In 4 cases (10%) CPB 
was not necessary because of 
direct closure of a false aneurysm 
at an easily accessible site (3 
patients) or the choice to perform a 
cerebrovascular vessel debranching procedure followed by insertion of an 
endoprosthesis (1 patient). In 14 patients, CPB was started before reentry into the 
thorax, and in 5 of them deep cooling and a short period of deep hypothermic 
circulatory arrest (DHCA) was installed before resternotomy. Cardioplegia was 
usually administered selectively into the coronary ostia (n = 25 of 34; 74%) and 
repeated when the ventricular septal temperature exceeded 10°C. Continuous topical 
cooling with cold Ringer’s lactate solution was used during cardiac arrest. The left 
ventricle was vented through insertion of a cannula in the right upper pulmonary 
vein. In 9 patients, cardioplegic arrest was not necessary. Mean CPB time was 188 
± 69 minutes (range, 21 to 324 minutes), and the mean duration of aortic cross-
clamping time was 102 ± 52 minutes (range, 5 to 212 minutes). Fifteen patients 
received an open distal anastomosis using DHCA. Deep hypothermic circulatory 
arrest alone was used in 7 patients (mean duration of circulatory arrest, 23 ± 16 
minutes; range, 5 to 39 minutes). In contrast, DHCA with the adjunct of antegrade 
bilateral cerebral perfusion was established in 8 patients. In these patients, the mean 
duration of DHCA and antegrade bilateral cerebral perfusion was 67 ± 24 minutes 
and 70 ± 42 minutes, respectively.
Statistical Analysis 
Continuous variables were expressed as the mean ± standard deviation. Eighteen 
perioperative risk factors were entered into a univariate analysis (standard Student’s 
t test,  2, or Fisher’s exact test when appropriate) to determine whether any single 
variable influenced the hospital mortality. These variables were sex, age, cause, 
emergency surgery, the presence of preoperative coronary artery disease, chronic 
obstructive pulmonary disease, preoperative cerebrovascular accident or 
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preoperative chronic renal failure, New York Heart Association class, left 
ventricular dysfunction, the number of previous operations requiring opening of the 
pericardium, CPB time, cross-clamping time, reintervention for bleeding or 
tamponade, postoperative renal failure, perioperative myocardial infarction, 
postoperative cerebrovascular accident, and postoperative infection. Each variable 
with a probability value of less than 0.05 was entered into a multiple logistic 
regression analysis model to study its independent predictability for hospital 
mortality. Survival rates and freedom from reoperation were calculated using the 
Kaplan-Meyer method. Statistical analyses were performed using the Stat-View 
Statistical Software Package version 5.0 (SAS Institute Inc, Cary, NC) and NCSS 
2001 (Number Cruncher Statistical System, Kaysville, UT). 
Results 
     
Clinical Presentation 
The false aneurysm was diagnosed during routine follow-up examination in 23 
asymptomatic patients. 
Symptoms varied according to the 
location and the size of the false 
aneurysm (Table 4).   
False Aneurysm Site and Cause 
Details of the false aneurysm site 
are reported in Table 5. 
The cause was unknown in 15 
patients.  
The interval between the prior and 
the actual operation in this cohort of patients was 12.2 ± 11.1 years. Disease of the 
aortic wall was present in 26 
patients; 7 of them were 
Marfan, and 17 had previous 
aortic dissection. Infection 
was the predominant cause in 
14 patients. Ten of them had 
evidence of severe infection 
during the postoperative  
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course after the prior operation (n = 10: sepsis, n = 8; mediastinitis, n = 2), in 3 cases, 
patients exhibited aortic valve endocarditis before the actual surgical procedure, and 
1 patient presented with mediastinitis. Only half of septic false aneurysm (n = 7; 
50%) had positive blood or aortic tissue cultures. Patients who had at least one 
recognizable etiologic factor received the reoperation for false aneurysm after a 
significantly shorter interval than patients with a negative etiologic history (6.7 ± 
6.5 years versus 12.2 ± 11.1 years; p = 0.03). A stronger difference was found in the 
subgroup with evidence of infection (4.6 ± 6.9 years versus 12.2 ± 11.1 years; p = 
0.01). Infection recurred as an independent risk factor (p = 0.02) for reoperation in 
an early period (<8 months; 1st quartile of interval, 74 to 243 days). 
In-Hospital Outcome  
There were no intraoperative deaths. The in-hospital mortality (mortality before 
discharge) reached 6.9% (3 patients). The mean postoperative hospital stay was 15 
± 14 days. After logistic regression analysis, preoperative coronary artery disease 
and postoperative sepsis were shown to be significant (p < 0.001) independent risk 
factors for in-hospital mortality. The postoperative course was complicated in 17 
cases (39%). Early reoperation for excessive bleeding or tamponade (n = 4; 9.3%) 
and for the removal of compress gauzes purposefully left in the thorax (n = 2; 4.6%) 
was necessary in 6 patients. Perioperative myocardial infarction occurred in 1 
patient (2.3%), and stroke occurred in 2 patients (4.6%). Four patients (9.3%) had 
pulmonary infections, and 3 sustained postoperative sepsis. We registered 1 case of 
mediastinitis, and in 3 patients (6.9%), a permanent pacemaker implantation was 
necessary for complete atrioventricular block.
Survival 
All patients were followed up at the outpatient clinic of our department or at 
peripheral sites. Mean follow-up time was 48 ± 51 months (range, 1 to 176 months), 
and it was available for all but 1 patient (97.5% complete). There were 5 late deaths; 
in 1 patient it was related to the operation performed. This patient had an 
aortopulmonary fistula and underwent an emergency operation. The cumulative 1-
year, 5-year, and 10-year survival rates (excluding hospital mortality) were 94%, 
79%, and 68%, respectively. Freedom from reoperation (excluding early in-hospital 
operation for bleeding) for recurrent aortic disease was 86% at 1 year and 72% at 5 
and 10 years. No difference was found in survival and freedom from reoperation 
according to false aneurysm cause. 
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Comment 
This study was undertaken to evaluate the outcome in a cohort of 43 patients 
undergoing reoperation for false aortic aneurysm after cardiovascular surgery during 
a period of 14 years. Hospital mortality was 6.9%, which is relatively low compared 
with previous reports that showed a mortality rate up to 18% [1, 4, 7, 8, 12]. Most 
of the literature available contains isolated case reports and small cohorts of patients 
[13–15]; more important experiences reported a mortality of 14% ± 7% [1, 4, 7, 8, 
12, 16–19]. 
Clinical Presentation 
In previous reports, 80% to 100% of the patients showed symptoms related to the 
presence of the false aneurysm [1, 4, 7, 8]. The most common presentation is chest 
pain, signs of heart failure, and sepsis for false aneurysms located in the ascending 
aorta, whereas tracheal compression was more common with involvement of the 
arch or descending thoracic aorta. The occurrence of compression or erosion of the 
surrounding structures and fistulas was less frequent [4, 7, 8]. In our experience we 
found similar clinical presentations, but we registered a significantly lower rate of 
symptomatic patients (20 of 43; 47%). 
In 23 asymptomatic patients, false aneurysms were detected during clinical and 
outpatient clinical computed tomographic (CT) scan guided follow-up. This could 
be explained by our strict yearly or annual CT scan guided follow-up specifically 
after aortic surgery independently from any symptoms and for a lifelong period [16]. 
This long-term follow-up is justified by the recurrence of aortic complications after 
several years from the prior operation. In our series, 7 patients (16%) had a 
reoperation 15 years after the previous surgical procedure. 
The presence of the false aneurysm, despite its size, represents the most important 
factor in surgical indication; false aneurysms have the general tendency to grow 
irrespective of their location, and of course this will always end in rupture. 
False Aneurysm Site and Cause 
In our series, most of the patients (93%) had an aortic procedure as their previous 
operation. False aneurysms developed in half of the cases on the proximal and distal 
suture lines of valve grafts previously implanted. Although the aortic cannulation 
site was reported by Sullivan and associates [17] as one of the most common sites 
of false aneurysm, this appeared to be unusual in most recent reports [4, 8] and 
confirmed by our experience. We could not show any relation between the size of 
the false aneurysm and the location (proximal or distal). 
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In one third of the cases we found infection, defined as prolonged prior 
postoperative febrile status owing to infection, sepsis, mediastinitis, development of 
endocarditis between the two operations, and a documented septic status at the 
reoperation, to be the main etiologic factor. This finding varies, according to 
different definitions (prior postoperative febrile status, mediastinitis, endocarditis, 
septic status at the reoperation) in previous reports, from 10% to 75% [1, 4, 7, 12, 
17]. A positive blood or tissue culture was described in a minority of patients 
suspected of having infected false aneurysm, ranging from 30% to 50% [1, 4, 17, 
18]. In most of the cases a Staphylococcus species was isolated. 
Mohammadi and colleagues [8] reported a higher incidence of postoperative false 
aneurysm after aortic procedure in the presence of aortic dissection, probably 
attributable to tissue fragility in the suture line. In contrast, our findings (40%) are 
similar to those reported by Atik and coworkers [4] and Katsumata and associates 
[1], with a dissection rate ranging from 25% to 50%. Aortic wall disease is a well-
known risk factor. Seven of our patients had Marfan syndrome and 1 had a 
documented Takayasu arteritis (19%). Kazui and colleagues [20] reported a 
reoperation rate of 36% (5 of 14 Marfan patients) after a mean follow-up of 8.4 
years. Excessive use of gelatin resorcinol formalin glue has been reported to cause 
tissue toxicity and necrosis [2, 3]. 
Recent reports raised a cautionary note about long-term sequelae also for albumin 
glutaraldehyde glue [21, 22]. We routinely use albumin glutaraldehyde glue chiefly 
outside the aortic wall over the suture lines in a dry field in all aortic replacement 
(redo) operations. We were not able to recognize in this cohort of patients a specific 
glue-related false aneurysm, but obviously a possible loss of tissue integrity might 
have predisposed to aortic wall degeneration. Despite our cautious but widespread 
use of biologic glue, we were able to find in a previous analyzed cohort of patients 
who underwent reoperation on the aortic root only 5 cases of aortic false aneurysm 
in the course of more than 500 aortic root procedures (period 2002 to 2009, patients 
who had a prior operation at St. Antonius Hospital) [23]. 
In our series, the mean interval between the previous and the actual operation was 
98 months (range, 2 to 452 months), which is slightly longer than those reported in 
previously published papers varying from 24 to 74 months [4, 7, 8, 17]. We do not 
believe that our longer interval could be responsible for a delayed diagnosis because 
of our policy of strict CT-guided follow-up. 
Sullivan and colleagues [17] reported no difference in interval between patients 
presented with or without signs of infection. We compared the interval of the 
patients with at least a well-recognized and documented risk factor (infection, 
previous aortic dissection, and wall disease) (80 ± 79 months) and patients without 
a well known etiologic factor (149 ± 123 months; p = 0.03). A stronger difference 
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was found considering the cohorts of patients characterized by infection and aortic 
dissection (p = 0.01) compared with the cohort without a well characterized etiologic 
factor. 
Surgical Technique 
A proper preoperative assessment is fundamental for carrying out a safe reentry into 
the chest. A preoperative CT scan is mandatory in every patient to delineate the 
relationship between aorta, the false aneurysm, the heart, and the sternum. Besides 
a CT scan, a lateral chest roentgenograph should aid in establishing the presence of 
retrosternal space (Fig 1). 
Fig 1. Computed tomography scan (A) and lateral radiographic (B) image of a 
patient with a false aneurysm (white arrows) rising from the proximal suture line. 
In this patient, cardiopulmonary bypass was started before reentry because of the 
close relationship between the sternum and the false aneurysm. 
Our policy is to start CPB before reentry only in the presence of less than 2 cm of 
space between mediastinal structures and the sternum. We reserved this strategy in 
14 patients; in 5 patients the chest was reopened during DHCA because of 
externalization of the false aneurysm such as aortocutaneous fistula or sternal 
erosion. In only 1 patient, a severe aortic regurgitation was present and we preferred 
to cool the patient slowly to 30°C to avoid ventricular fibrillation and ventricle 
distention. As reported by other authors [4, 18], a small left anterior thoracotomy 
with placement of an intraventricular vent cannula can accomplish a satisfying heart 
decompression under transesophageal echocardiographic guidance. This strategy 
resulted in reentry complications in 5 patients. In 3 patients, this possibility was 
judged as highly probable and patients were already on CPB or in DHCA. 
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Other strategies were described in the literature, and in every case the decision about 
managing chest reentry was taken after a careful evaluation of the risk of rupture. 
Settepani and coworkers [7] and Katsumata and associates [1] suggested to start 
CPB followed by cooling the patient down to 16° to 18°C or 22°C in case of less 
than 2 cm of space under the sternum and just to 28°C if the false aneurysm appeared 
to have no relation with the sternum [7]. Mohammadi and colleagues [8] reported 
their strategy as the preference to cannulate the two carotid arteries separately to 
avoid brain hypoperfusion and air embolism in case of high risk of false aneurysm 
rupture. A similar proposal for brain protection was reported by Bachet and 
associates [24]. 
Aortic graft replacement is our strategy of choice with 70% of the patients receiving 
an extensive repair and aortic substitution. Similar operative techniques were 
reported in the other large series in the literature by Atik and colleagues [4] with 
only 28% of patients undergoing direct suture or patch repair of the false aneurysm. 
We always implant two separate tubes (either in Bentall plus ascending or 
supracoronary ascending replacement); the reason for this is that the angle between 
the aortic valve and the distal ascending aorta and proximal arch is 90 degrees; in 
this way the original anatomy of the aorta is respected. In our opinion, implantation 
of a single tube might result in some extra tension in the noncoronary sinus suture 
line that may lead to a higher risk for false aneurysm formation. An extensive 
debridement and excision of all necrotic and infected tissue is mandatory to avoid 
the occurrence of sepsis or mediastinitis and the recurrence of the false aneurysm. 
In these patients we recommend the use of a homograft and biologic conduit and a 
strict postoperative follow-up with 6 weeks of systemic antibiotic therapy 
postoperatively [23]. 
Simple repair is not the optimal solution also in uninfected patients because of the 
fragility of the suture line tissue that may lead to early complications or the 
development of a new false aneurysm [8]. However, in severely ill patients, closure 
of the false aneurysm is the only proper lifesaving procedure, especially in 
uninfected patients with a small aortic leakage lesion.  
Outcome 
Our mortality rate (6.9%) is similar to those reported in the two other major cohorts 
of patients who underwent reoperations for false aneurysm (Atik and associates, 
6.7% [4]; cumulative survival including non-postsurgical false aneurysm, 50 of 60 
patients; Villavicencio and coworkers, 7% [18]; cumulative survival including 
nonpostsurgical false aneurysm; 37 of 58 patients).
The cumulative 1-year, 5-year, and 10-year survival rates (excluding hospital 
mortality) is 94%, 79%, and 68%, respectively, and comparable with the experience 
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of the Mayo Clinic [18] and the Cleveland Clinic [4]. A satisfying freedom from 
reoperation (86% and 72% at 1 year and at 5 and 10 years), comparable to previously 
published reports, underlines the efficacy of these procedures with a low rate of 
operative technical problems and encouraging survival. However, the postoperative 
morbidity rate is high. 
Unless our experience in this series is limited to one debranching procedure 
followed by insertion of an endoprosthesis, there are some recent reports in the 
literature about an endovascular approach for closure of an aortic false aneurysm [5, 
6, 25, 26]. This new approach appears to be promising, especially in the treatment 
of lesions located in the descending thoracic aorta [27, 28]. The high rate of false 
aneurysm development at the coronary reimplantation site and the ascending aortic 
suture line, often in close relation with the cerebral vessels, emphasizes the need for 
a feasible and satisfying surgical procedure as the only proper treatment for this life-
threatening disease. 
Conclusions 
This study emphasizes the need of continuous follow-up with CT or magnetic 
resonance imaging at regular intervals after aortic surgery. Reoperation for 
postsurgical aortic false aneurysm is still a complex operation that necessitates 
extensive preoperative workup. Early and late survival and freedom from 
reoperation are good, although the postoperative course is characterized by a high 
morbidity rate. 
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INVITED COMMENTARY 
The treatment pendulum is swinging in many areas of aortic surgery away from 
open repair toward a less invasive approach using endovascular technologies. 
However, the current study by Dr Malvindi and colleagues [1] demonstrates with 
regards to the complex subject of reoperation for aortic pseudoaneurysms after prior 
cardiac operations that open surgical repair remains the most prudent and successful 
approach. Several factors lead to the development of aortic pseudoaneurysms in 
patients with a history of cardiac operations; however, it appears that it is becoming 
a more frequent diagnosis. This study describes 43 cases of aortic pseudoaneurysm 
in patients with prior cardiac operations over a 14-year period. Many of these 
patients were asymptomatic at the time of diagnosis, which demonstrates the clinical 
need for regular computed tomography screening in any patient with a previous 
aortic operation. In addition, with more high-resolution computed tomography scans 
being performed, various other focal aortic defects are being identified that may 
require the same surgical treatment principles as described in their article. 
One of the most critical aspects of this type of surgical repair is the management of 
cardiopulmonary bypass cannulation to most safely reenter the chest. Before the 
chest was opened, 14 patients in this series had initiation of cardiopulmonary bypass 
and 5 patients in this series needed hypothermic circulatory arrest due to adherence 
of the aortic pseudoaneurysm to the posterior aspect of the sternum. The authors use 
the criteria of less than 2 cm of distance between the sternum and the aortic 
aneurysm on preoperative imaging on when to pursue this approach. Certainly, the 
excellent outcomes described in this article are directly related to the success of this 
algorithm. 
The final important surgical principle that their article highlights is the need for 
extensive debridement of the pseudoaneurysm and surrounding aortic tissue. One 
third of the pseudoaneurysms were related to infection, and 70% of the patient 
cohort received an aortic graft replacement. Without aggressive repair, these lesions 
may recur or achieve an inadequate resection. 
As the authors correctly discuss, endovascular techniques, including hybrid repair, 
have been described for the treatment of this problem. However, with the excellent 
surgical outcomes listed in this article, it is difficult to deny patients an open surgical 
resection. Some patients at high surgical risk may benefit from the less invasive 
approach, but all of the patients in this study were undergoing redo procedures and 
had many medical comorbidities. In addition, many of the lesions described in this 
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report were in an unfavorable location for an endovascular approach. Until 
endovascular technologies advance significantly, an open surgical repair using the 
principles and techniques listed in this article for aortic pseudoaneurysms in patients 
with prior cardiac operations should be considered the definitive approach. 
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Abstract 
Postsurgical aortic false aneurysm occurs in less than 0.5% of all cardiac surgical 
cases and its management is a challenge in terms of preoperative evaluation and 
surgical approach. Although infections are well recognized as risk factors, technical 
aspects of a previous operation may have a role in pseudoaneurysm formation. The 
risk factors and clinical presentation of pseudoaneurysms and the surgical strategy 
are revisited in this article. 
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Aortic false aneurysm, or pseudoaneurysm, is a rare complication after aortic 
surgery requiring reoperation and occurring in less than 0.5% of all cardiac surgical 
cases [1,2]. Predisposing factors include graft infection and mediastinitis, 
progressive aortic wall disorder, dissection of the native aorta and excessive use of 
biologic glue [3,4]. The uses of modern monofilament suture and low-porosity 
collagen-impregnated or gelatin-impregnated Dacron grafts [5], as well as the 
abandonment of the inclusion cylinder technique [6], have lessened the incidence of 
this complication. 
Case report 
An asymptomatic 78-year-old man was admitted to our hospital after routine 
transthoracic echocardiography (TTE) images showed a suspected aortic false 
aneurysm (Fig. 1a–d). Ten years prior to presentation he underwent aortic root and 
aortic valve replacement according to modified Bentall–De Bono operation [7] for 
an aortic root 
aneurysm and stenotic 
bicuspid aortic valve. 
Three coronary artery 
bypass grafts, a left 
internal mammary 
artery (LIMA) to left 
anterior descending 
and a sequential 
saphenous vein graft 
to the right coronary 
artery (RCA) system 
and to the obtuse 
marginal branch, 
were also performed. 
The proximal valved 
graft anastomosis was 
performed with three 
polypropylene 2/0 running sutures and a biologic glue was used to reinforce the 
suture line. The previous operation was uneventful and the patient was discharged 
on the seventh postoperative day. The patient had no history of postoperative 
infections or endocarditis during follow-up. A contrast medium chest computed 
tomography (CT) scan evaluation detected an aortic false aneurysm of 42±12mm 
originating from the proximal valved graft anastomosis, partially compressing the 
tubular portion of the vascular graft (Fig. 2a, b). Patency with the LIMA graft was 
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certified, whereas the saphenous vein graft turned out to be occluded. Severe 
calcifications with RCA, abdominal aorta and femoral vessels were also detected at 
chest CT scan (Fig. 2b). Invasive coronary angiogram was not performed due to the 
risk of catheter pseudoaneurysm perforation. TTE demonstrated an ejection fraction 
of 45% and a normal function and positioning of the aortic-valved graft. After 
careful evaluation of the aorta,  
false aneurysm, heart and sternum relationship, the patient was considered for 
elective surgery. Femoral vessels were isolated but not cannulated before 
resternotomy, considering the presence of a wide retrosternal space in front of the 
pseudoaneurysm; the distance and the lateral course of both the LIMA graft and the 
right ventricle from the posterior sternum; and in order to establish a quick 
cardiopulmonary bypass (CPB) in case of mediastinal structure damage. After 
sternal reopening and lysis of adhesions, the distal ascending aorta and right atrium 
were cannulated and CPB was started. The LIMA graft was isolated and clamped in 
order to avoid ‘cardioplegia washout’ and regional myocardial rewarming after 
aortic cross clamp (ACC). Cardiac arrest was obtained by retrograde cold crystalloid 
cardioplegia. Systemic cooling to 32°C was carried out. The tubular part of the 
valved graft was opened and an aortic false aneurysm was detected as described by 
the CT scan. Rupture of the proximal valved graft anastomosis was observed (Fig. 
3). Expansion towards sutured right coronary ostia with dislocation of the RCA was 
also detected. The portion of the detached valve ring was reimplanted with 
interrupted polyester 2/0 pledget-supported sutures. The right coronary ostium 
appeared calcified and affected by intimal lesions, therefore it was closed by means 
of a saphenous vein patch. To decrease the tension, a new 30mm tubular Dacron 
graft was interposed between the valved graft and the ascending aorta remnant. A 
saphenous vein graft was then performed on the RCA after tromboendoarterectomy. 
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No coronaries suitable for surgery were found on the lateral wall of the heart. CPB 
and ACC time were 198 and 158 min, respectively. Operative tissue samples were 
cultured and no signs of infections were found. The postoperative course was 
uneventful and the patient was discharged on the eighth postoperative day. Chest 
CT scan and TTE checking showed no leak.  
Postsurgical aortic 
false aneurysm is a 
rare but life-
threatening 
complication. The 
presence of the 
false aneurysm, 
despite its size, has 
been always 
considered an 
indication for 
surgical repair 
[1,8]. The mortality 
rate reported in the 
literature ranged 
from 7 to 18% 
[1,2,8-10] and, 
even in larger experiences presenting lower in-hospital mortality, the postoperative 
morbidity rate is still high. Complications were reported in 30–40% of the cases. 
Early reoperation for excessive bleeding or tamponade was necessary in 8–9% of 
the patients. Postoperative infections and sepsis were described in 10–15% of the 
cases. Cerebrovascular accidents had acceptable incidence 3.3–5% [1,8]. The 
evolution of these lesions is unpredictable [11], so the surgical option should always 
be discussed even with asymptomatic patients. 
False aneurysm risk factors and site 
Graft infection and mediastinitis, progressive aortic wall disease, dissection of the 
native aorta [12], and excessive use of biologic glue [3,4] are recognized as etiologic 
factors. In a recent series[1], perioperative infections strongly correlated with 
postsurgical pseudoaneurysm formation and this finding varies from 10 to 75% in 
other reports [2,8-10]. Pathological aortic wall diseases, such as Marfan syndrome 
or arteritis, are risk factors [1]. Also, poor anastomotic techniques have been 
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described as a technical factor influencing pseudoaneurysm formation [7], as well 
type of prosthetic graft13 and anastomotic suture materials [14,15]. The uses of 
modern monofilament suture have lessened the incidence of pseudoaneurysm 
formation [16]. Although our patient presented two risk factors predisposing to the 
disease (bicuspid native aortic valve [17] with associated aortic wall pathology [18] 
and biologic glue use) operative findings showed anomalous spontaneous suture line 
rupture. The aortic cannulation site was reported by Sullivan et al. [10] as one of the 
most common sites of false aneurysm; however, this is not confirmed in most recent 
reports [8]. In a series of 43 patients, Malvindi et al. [1] reported false aneurysm 
development in half of the cases on the proximal and distal suture lines of valve 
grafts previously implanted, and this was also confirmed by our experience [9]. 
Symptoms and follow-up 
Chest pain and dyspnea [19] are the most common clinical presentations. 
Pseudoaneurysms are frequently asymptomatic in the early stages, so CT scan 
guided follow-up is mandatory in postsurgical aortic patients [1,20,21]. Our patient 
was asymptomatic and the pseudoaneurysm was detected in another hospital by a 
routine TTE performed 10 years after operation. No previous TTEs were available 
and we could not establish when the aortic false aneurysm appeared. We believe 
that long-term survival of patients having aortic surgery, especially of high risk, can 
be improved by strict clinical and imaging (TEE and/or CT scan) follow-up in the 
cardiac center of referral. 
Surgical technique 
Aortic false aneurysm lesion during sternal re-entry can have catastrophic 
consequences and is estimated to range from 11 to 40% [1,2,9]. Our preoperative 
assessment and surgical strategy in aortic false aneurysm management have been 
described previously [9]. We suggest starting CPB before resternotomy followed by 
cooling the patient down to 16–18 or 22°C when the pseudoaneurysm is located less 
than 2 cm from the sternum. Others are consistent with our technique [2]. The case 
reported was complex in terms of surgical approach (reoperation, pseudoaneurysm, 
patent LIMA graft) and myocardial protection. During a true re-root procedure, the 
need for unscheduled coronary artery bypass grafting has been shown to be a 
significant risk factor [22]. In our case we planned preoperatively the possibility of 
performing a saphenous graft on the distal RCA. The presence of severe 
calcification at the proximal site of the RCA and the marked intimal disruption at 
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the right coronary ostium forced us to close the right ostium. Our approach 
(exposure of femoral vessels, LIMA clamping, retrograde cardioplegia with 32°C 
of body temperature) was safe and we did not register ischemic complications 
(maximum postoperative troponin I peak was 4.8 ng/ml). In conclusion, reoperation 
for postsurgical aortic false aneurysm is a complex and challenging procedure. 
Technical aspects of the previous surgery are important risk factors in 
pseudoaneurysm development. Clinical surveillance and standardized follow-up 
protocols of the referred cardiac center may influence long-term survival in aortic 
surgery patients. The endovascular approach [23] appears to be promising, 
especially in treatment of lesions located at the descending thoracic aorta; however, 
the high rate of false aneurysms at unfavourable locations for endovascular 
therapies, that is coronary reimplantation and ascending aorta suture lines, suggests 
that open surgical repair is the most prudent, successful and, in most cases, definitive 
approach [1]. 
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Abstract 
Aortic false aneurysm is a rare complication after cardiac surgery. In recent years, 
improved results have been reported in regard to the surgical management of these 
high risk lesions.  
We retrospectively examined 28 consecutive cases (in 27 patients) of postsurgical 
aortic false aneurysm diagnosed at our institution from May 1999 through December 
2011. Twenty-four patients underwent reoperation. Cardiopulmonary bypass was 
instituted before sternotomy in 15 patients (63%). Isolated repair of the aortic false 
aneurysm was performed in 15 patients. Four patients (including one who had 
already undergone repeat false-aneurysm repair) declined surgery in favor of 
clinical monitoring.  
Eleven patients were asymptomatic at the time of diagnosis. In the other 16, the 
main cause was infection in 7, and previous operation for acute aortic dissection in 
9. The in-hospital mortality rate was 16.6% (4 patients, 3 of whom had infective 
false aneurysms). Relevant postoperative sequelae were noted in 7 patients (29%). 
The cumulative 1-year and 5-year survival rates were 83% and 62%, respectively. 
The 4 patients who did not undergo reoperation were alive at a median interval of 
23 months (range, 9–37 mo). Two underwent imaging evaluations; in one, computed 
tomography revealed an 8-mm increase of the false aneurysm’s maximal diameter 
at 34 months.  
Aortic false aneurysm can develop silently. Surgical procedures should be proposed 
even to asymptomatic patients because of the unpredictable evolution of the 
condition. Radical aortic-graft replacement should be chosen rather than simple 
repair, because recurrent false aneurysm is possible. 
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Aortic false aneurysm is a rare sequela of surgery on the thoracic aorta [1]. Infection, 
pathologic conditions of the aortic wall, dissection of the native aorta, and excessive 
use of biological glue have been recognized as causative factors [2,3]. The 
development and expansion of aortic false aneurysms is often silent [3]. Their 
evolution is unpredictable, and rupture can be fatal. Despite advances in 
endovascular techniques, the treatment is chiefly surgical [4]. In recent years, 
improved results in surgical management have been reported [4-6]; however, 
treatment is still burdened by a high morbidity rate. 
Herein, we provide the midterm results of our experience in the treatment of this 
challenging pathologic condition, and we discuss the evolution of aortic false 
aneurysm in patients who declined surgical repair or were deemed unsuitable for 
reoperation. 
Patients and methods 
We retrospectively examined 28 consecutive cases (in 27 patients) of postsurgical 
aortic false aneurysm diagnosed at our institution from May 1999 through December 
2011. These lesions involved the thoracic aorta from the aortic root to the distal arch. 
Twenty-four of the patients underwent reoperation. The mean age at the time of 
reoperation was 64 ± 15 years (range, 21–87 yr) and 17 of the 24 patients (71%) 
were men. Two patients had Marfan syndrome. The median interval between the 
previous procedure and reoperation was 3.6 years (range, 1 mo–21.9 yr). The mean 
follow-up period was 46 ± 40 months (range, 1–147 mo). Four patients, including 
one previously reoperated on for aortic false aneurysm, declined reoperation or were 
deemed unsuitable for a repeat procedure and entered clinical monitoring. Their 
mean age upon the diagnosis of false aneurysm was 67 ± 12 years, and the median 
interval between their prior operation and the detection of the lesion was 6.5 years 
(range, 5.5–12.3 yr). Our local ethics committee waived the need for informed 
consent in this study. 
Previous Operations Performed 
The indications for cardiac surgery at the previous surgical procedure were aortic 
aneurysm (12 of 27 patients; 44%), acute aortic dissection (8 patients; 30%), 
pathologic conditions of the aortic valve (4 patients; 15%), repeat aortic false 
aneurysm in 1 patient already operated on for that condition, mitral regurgitation (1 
patient), and coronary artery disease (1 patient). Twenty-one patients had undergone 
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previous aortic surgery, and the use of BioGlue® (CryoLife Inc.; Kennesaw, Ga) 
was reported in 12 of those cases. Table I lists the previous operations and 
concomitant procedures performed. 
Indications for Reoperation and the Surgical Technique 
The presence of a postsurgical aortic false aneurysm, regardless of size, was the 
main indication for reoperation 
in all patients. False aneurysm 
was defined as a lesion 
containing blood, resulting from 
disruption of the arterial wall 
with extravasation of blood 
contained by periarterial 
connective tissue and not by the 
arterial wall layers. 
A median sternotomy approach 
was invariably used. 
Cardiopulmonary bypass (CPB) 
was instituted before 
sternotomy in 15 of 24 patients 
(63%): through the femoral 
vessels in 14 patients, and through the right axillary artery and femoral vein in 1 
patient. In the other 9 patients, CPB was started after sternotomy: in 5 through the 
femoral vessels, in 2 through the right axillary artery and right atrium, and in 2 via 
aortic–right atrial cannulation. 
We have already described our algorithm in managing resternotomy in relation to 
false-aneurysm location [7]. Initially, this strategy usually involved CPB before 
reentry; however, as we gained experience, we began to start CPB before 
resternotomy only in the instance of a minimal space between the aorta or the heart 
and the posterior aspect of the sternum, as shown on chest imaging. In 2 patients, 
we chose to perform repeat sternotomy during a short period of deep hypothermic 
circulatory arrest (DHCA) because the lesion firmly adhered to the chest (Fig. 1). 
Because of severe aortic regurgitation and a false aneurysm adhering to the sternum 
in one patient, we performed—adjunctively to CPB before sternotomy—a small left 
anterior thoracotomy with a placement of an intraventricular vent cannula to achieve 
satisfactory decompression of the left ventricle. In 4 patients, the false aneurysm 
ruptured during repeat sternotomy. In 2, CPB had been already established before 
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the reentry. In the other 2, CPB was promptly started through the already-dissected 
femoral vessels, and blood loss was successfully managed in such a manner as to 
avoid hemodynamic imbalance and systemic hypoperfusion. Closure of the false 
aneurysm’s entry 
site by means of 
direct suturing 
was performed in 
15 of the 24 
patients (63%), 
whereas a more 
complex and 
extensive 
procedure was 
necessary in the 
other 9. Table II 
describes the 
operative 
procedures that 
were performed. 
The mean CPB 
time was 152 ± 75 
minutes (range, 
66–318 min), and 
the mean duration 
of aortic 
crossclamping 
was 96 ± 58 
minutes (range, 
4–220 min). In 
one patient, aortic 
cross-clamping 
and cardioplegic 
arrest were not 
necessary, because the false aneurysm’s entry site was easily accessible. In 5 
patients, DHCA alone was used (mean duration, 16 ± 8 min); moderate hypothermic 
circulatory arrest and antegrade bihemispheric selective cerebral perfusion were 
used in one patient (perfusion time, 21 min). In 3 patients, we were unable to 
reestablish normal coronary perfusion. In one, we placed a venous graft in the right 
coronary artery because of signs of ischemia during weaning from CPB. In the other 
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2 patients, it was necessary to interpose a Dacron graft between the vascular 
prosthesis and the right coronary ostium. 
Statistical Analysis 
Continuous variables were expressed as mean ± SD. Survival rates and freedom 
from reoperation were calculated by means of the Kaplan-Meier method. Statistical 
analyses were performed with use of the Stat-View Statistical Software Package 
version 5.0 (SAS Institute Inc; Cary, NC) and NCSS 2001 (NCSS; Kaysville, Utah). 
Results
Aortic false aneurysm was diagnosed during routine follow- up examination in 11 
asymptomatic patients. Table III presents the symptoms reported in the other 16 
patients. Sites and Causes of the Aortic False Aneurysms Details of the false-
aneurysm sites are reported in Table IV. Nine patients had undergone previous acute 
aortic dissection repair, 2 patients had Marfan syndrome, and 1 was diagnosed with 
Loeys-Dietz syndrome. 
In 7 patients, we found 
infection to be the main 
cause. Along with 
intraoperative f indings, 
diagnosis was def ined by 
the presence of positive 
preoperative blood cultures, 
intraoperative tissue 
cultures, or both; and by a 
patient’s history of 
mediastinitis, endocarditis, or sepsis characterized by false-aneurysm development 
within a reasonable time. In 6 patients, evaluation by computed tomography (CT), 
positron emission tomography, or echocardiography was performed soon after the 
infectious symptoms occurred; however, these methods did not reveal the aortic 
false aneurysm. The mean interval between infection and aortic false-aneurysm 
detection was 5 ± 2 months. 
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One patient developed aortic false aneurysm with fever and dyspnea 3 months after 
hospitalization, because of 
staphylococcal sepsis. Similar 
symptoms were found in a 
patient who underwent 
reoperation for aortic 
false aneurysm 7 months after 
ascending aorta replacement 
that had been complicated by 
sternal-wound infection (no 
culture results were then 
available); at reoperation, 
blood cultures and tissue 
samples were negative. 
Five patients had aortic false aneurysms diagnosed during hospitalization for septic 
conditions, as follows: 2 patients had Enterococcus faecalis, one had methicillin- 
resistant Staphylococcus aureus (MRSA), and one had Streptococcus mitis; and the 
patient with MRSA had composite-valve-graft prosthetic endocarditis. In 2 of the 5 
patients, aortic tissue cultures had the same bacterial positivity as their blood 
cultures. 
In-Hospital Outcomes 
The in-hospital mortality rate was 16.6% (4 patients). Three of the 4 patients had 
infective aortic false aneurysms, and one presented with preoperative septic shock. 
The postoperative course was complicated in 7 
patients (29%). Early reoperation for excessive bleeding was necessary in 2 patients 
(9%). In 4 patients, neurologic deficits occurred, one permanent and 3 transient. In 
3 patients, pulmonary insufficiency necessitated longer respiratory weaning times 
and longer stays in the intensive care unit. 
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Survival and Reoperation 
Surgical Population. The 
mean follow-up time for 
all the patients was 46 ± 
40 months (range, 1–147 
mo). 
There were 6 late deaths; 
the cumulative 1- and 5-
year survival rates were 
83% and 62%, 
respectively (Fig. 2). 
Three patients had 
recurrent aortic false 
aneurysm. In all 3, false-
aneurysm closure had 
been performed by means 
of direct suturing during 
the previous procedure. 
Two underwent a second reoperation. Overall freedom from recurrence of aortic 
false aneurysm was 100% and 80% at 1 year and 5 years, respectively. 
Clinical Monitoring. The first patient who declined reoperation in favor of clinical 
monitoring was a 77-yearold 
man who presented in poor general condition aggravated by neurocognitive deficit. 
Aortic false aneurysm was diagnosed 70 months after a Bentall operation, and CT 
showed a left coronary ostium 
leak with a maximal lesion 
diameter of 20 mm. He underwent 
regular CT follow-up scanning, 
which showed an increase of 8 
mm in the maximal diameter of 
the aneurysm at 34 months. The 
2nd patient, a 77-year-old man 
who underwent annual CT 
monitoring, had been diagnosed 
with aortic false aneurysm at the 
proximal suture line 149 months after supracoronary ascending aorta replacement. 
He declined reoperation and further CT scanning. He was alive and asymptomatic 
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9 months after diagnosis. The 3rd patient was a 59-year-old man who had undergone 
supracoronary ascending aorta and aortic valve replacement for acute aortic 
dissection and subsequent reoperation for aortic root replacement (Bentall 
procedure). After 66 months, an aortic false aneurysm at the distal ascending suture 
line was detected, during CT scanning for respiratory insufficiency caused by 
chronic obstructive pulmonary disease and right hemidiaphragm elevation. Diffuse, 
substantial calcification was seen at the proximal arch and descending thoracic 
aorta. The patient declined reoperation because of the extent and risk of the 
procedure. He was alive 11 months after diagnosis. The 4th patient, a 48-year-old 
woman, had Loeys-Dietz syndrome and had already undergone surgery for an aortic 
false aneurysm arising from the right coronary ostium suture line. Twenty-six 
months after that operation, echocardiography revealed an aortic false aneurysm at 
the proximal composite-valve-graft suture line. She declined further surgery and 
underwent yearly echocardiographic examination. At 37 months after diagnosis, the 
maximal diameter of the aneurysm was stable (17 mm) and she was asymptomatic. 
Discussion 
Since the late 1990s, investigators have reported acceptable in-hospital mortality 
rates and satisfactory midterm outcomes in patients operated on for aortic false 
aneurysm (Table V)[1,4-6,8-11]. These experiences enabled determination of the 
most successful strategies for chest re-entry [4,5,7,9,12]. 
Patients with aortic false aneurysm can present with chest pain, dyspnea, and fever, 
and less frequently with mass-effect symptoms or erosion of surrounding structures 
[1,5,9]. Asymptomatic patients can be diagnosed with false aneurysm during routine 
monitoring and several years after the prior operation [4,5,7-9]. This was confirmed 
in our cohort, in which 6 patients (24%) underwent diagnosis and reoperation 10 
years after their previous surgical procedures. These findings justify long-term 
monitoring after aortic surgery, especially in the presence of recognized risk factors 
for aortic false-aneurysm development: previous aortic dissection, inherited 
connective- tissue disorders, or postoperative graft infection, sepsis, or mediastinitis 
[1,4,7-9,13]. The use of biological glues at the suture lines is reportedly a chief cause 
of aortic wall disruption [10,14]; however, the cautious use of albumin 
glutaraldehyde glue has been shown to be safe and advisable [15]. 
Infection is the most threatening condition, because of systemic involvement and 
the frailty of tissues. Previously, infection was reported to be the main cause of aortic 
false aneurysm in a widely variable number of patients, from 10% to 75% 
[1,4,5,7,8,16]. This great variability probably arises from different definitions of 
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infection as a cause: prior postoperative febrile status, mediastinitis, endocarditis, or 
septic status at reoperation. Furthermore, positive blood cultures, tissue cultures, or 
both were described in half or fewer of these patients (30% – 50%) [1,5,6,8]. We 
have described 7 cases of patients who presented with infective postsurgical aortic 
false aneurysm. The diagnosis was confirmed by intraoperative findings and 
supported by preoperative positive blood cultures in 5 patients (with concordant 
tissue cultures in 2 cases) and a reasonable time correlation between systemic or 
sternal wound infection and false aneurysm diagnosis. Of note, evaluations with use 
of CT, positron emission tomography, or echocardiography were performed in 6 of 
7 patients soon after the appearance of fever and signs of systemic inflammation, 
but these methods did not detect an aortic false aneurysm thus revealing the 
pathogenic role of infection in suture-line disruption and false-aneurysm 
development. The prior postoperative history of these patients was characterized 
either by early onset fever and sternal-wound complication necessitating antibiotic 
therapy, or by sepsis after pulmonary infection or subsequent invasive medical 
procedures (such as chronic dialysis or abdominal surgery). Although such 
occurrences may not be unusual during a postoperative course, early symptoms and 
signs of inflammation should arouse suspicion of systemic infection. If infection is 
confirmed by positive blood or tissue cultures, targeted antibiotic therapy for 4 to 6 
weeks should be started promptly. The natural history of aortic false aneurysm is 
still not well defined [17,18] so the mere presence of that lesion, regardless of size, 
has been considered an indication for surgical repair [4,5,9]. 
We monitored 4 patients, all asymptomatic, who did not undergo reoperation (in one 
case, because of generally poor clinical condition). The follow-up time has been 
relatively short, and only 2 patients agreed to further imaging evaluations. In the 
first, during a 37-month period, imaging showed an almost unchanged maximal 
diameter of a false aneurysm arising from the proximal suture line of a composite 
valve graft; in the other patient, routine CT revealed an 8-mm increase in a false 
aneurysm arising from the left coronary ostium. These findings could suggest that a 
conservative approach be taken in asymptomatic patients with a small aortic false 
aneurysm; however, the evolution of the lesion is unpredictable, and late rupture or 
related sequelae could indicate the need for an emergent operation with 
unacceptable operative risk. In addition to symptomatic patients in whom 
reoperation should not be delayed, all asymptomatic patients diagnosed with aortic 
false aneurysm should be informed of the possible life-threatening evolution, and 
surgical options should be discussed with those in whom surgery would be 
appropriate. In regard to repair techniques, isolated direct closure of the lesion’s 
neck was performed in 15 patients (63%); accordingly, our rate of extensive repair 
with aortic-graft replacement is much lower than that reported in studies with larger 
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populations [4-6,9]. Direct closure is not the optimal solution in uninfected patients 
because of the fragility of the suture-line tissue.9 Three of our patients had recurrent 
aortic false aneurysm after a simple repair. Similar findings had already been 
reported by Katsumata and colleagues [1] and Villavicencio and associated [6]. 
However, at reoperation, patients’ conditions need to be evaluated carefully, and 
closure of the aneurysm might be the only appropriate life-saving procedure in 
severely ill patients. The opportunity to avoid open surgery is appealing, especially 
in patients who present in critical condition preoperatively. Percutaneous stent-graft 
placement, device occluder implantation, and coil embolization have been proposed 
for the treatment of false aneurysm of the thoracic aorta [19-21]. Endovascular 
techniques have some limitations, depending on the location of the false aneurysm 
and the size of the communication in the tear. Stent-grafts require adequate landing 
zones and might not be a safe option in proximity to the coronary ostia and supra-
aortic vessels. Coil embolization could be effective in small aortic false aneurysms 
with narrow necks; however, reports of these procedures are anecdotal [22]. 
Occluder devices could be used more extensively, but the absence of firm tissue, 
especially in infective lesions, increases the risk of device migration and 
embolization and the possibility of residual leak. The results reported in case reports 
and small case series are inconsistent with a cumulative intraprocedural success rate 
of about 86% (12 of 14 patients) [20]. This finding does not include postoperative 
sequelae, such as device dislodgment or persistent flow in aortic false-aneurysm 
chambers; furthermore, the follow-up data are sparse. The effectiveness and safety 
of transcatheter procedures are still not optimal, so surgical repair has to be 
considered the procedure of choice for treating false aneurysms in patients who 
present in acceptable general condition. Infective false aneurysms suggest higher-
risk conditions, especially in association with sepsis. Less invasive treatment might 
be advisable for these patients; however, the necessity of complete tissue 
debridement and extensive repair are the cornerstone in controlling infective lesions 
and avoiding recurrence. 
In summary, aortic false aneurysm occurs infrequently after cardiovascular surgery. 
Its development and 
growth can be silent, and routine monitoring should be suggested to all patients who 
have undergone aortic surgery. This policy is crucial in the presence of aortic wall 
pathologic conditions, in patients who have infections in the early postoperative 
period, and in patients who have recurrent or persistent signs of active inflammation. 
We think that surgery should be proposed to asymptomatic patients if clinical 
conditions permit, and that radical aortic-graft replacement is preferable to simple 
repair because of the possible recurrence of postsurgical 
aortic false aneurysm. 
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Abstract 
Background. The increasing use of biologic conduits and the advances in reparative 
aortic root procedures has increased the number of patients who may require 
reoperation on the aortic root. Although the primary operation yields excellent 
results with a low risk for morbidity and mortality, reoperation on the aortic root is 
still challenging.
Methods. We reviewed retrospectively our experience in 46 patients (38 men; mean 
age, 57 ± 11 years) who underwent aortic root reoperations in the last 7 years. Of 
these, 42 had received prior aortic root replacement. The indications for reoperation 
included prosthesis infection in 16, false aneurysm in 16, and degenerative or 
postdissection aneurysm and valve prosthesis failure. Aortic root re-replacement 
was performed in 39 patients (85%) and closure of false aneurysm in 7. Univariate 
and multivariate analysis on 22 perioperative variables were performed. 
Results. In-hospital mortality was 6.5% (3 patients). The postoperative course was 
complicated in 19 (41%). At multivariate analysis, perioperative myocardial 
infarction was a risk factor for hospital mortality (2 patients). Survival was 88% at 
1 year and 74% at 5 years. No differences were found in survival according to redo 
indication. Freedom from reoperation on the aortic root was 100% at 1 year and 
90% at 5 years. 
Conclusions. Reoperation on the aortic root can be performed with acceptable 
mortality and good midterm and long-term outcome; however, the postoperative 
complication rate is still high. 
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The first successful replacement of the aortic valve and ascending aorta was 
performed by Wheat and colleagues in 1964 [1]. Four years later, Bentall and De 
Bono [2] described a technique for total aortic root replacement using a composite 
graft containing a prosthetic valve while reimplantation of the coronary ostia was 
performed end-to-side. Surgical modifications and several technical improvements 
during the last 3 decades have made these procedures safe and reproducible, with 
an expected mortality in elective setting of less than 5% [3, 4]. 
The increased use of biologic conduits and the advances in reparative aortic root 
operations have increased the number of patients who may potentially require 
reoperation of the aortic root. Furthermore, prosthetic valve endocarditis and 
formation of false aneurysms are indications for repeat aortic root operations [5, 6]. 
Although these procedures yield excellent results as a primary procedure, 
reoperations in patients with previous cardiac procedures, and especially in patients 
with previous aortic root operations, are still challenging and result in a higher 
mortality rate [7–11]. The purpose of this study was to review our experience and 
clinical outcome in patients who underwent reoperation on the aortic root. 
Patients and Methods 
The Ethics Committee of St. Antonius Hospital approved this study and waived the 
need for patient consent. 
Patients 
Between February 2002 and April 2009, 561 consecutive patients underwent aortic 
root operations. Within this group, 46 patients had undergone at least one previous 
aortic root operation, and their records were retrospectively examined. The mean 
patient age at the time of reoperation was 57 ± 11 years (range, 35 to 78 years), and 
38 (83%) were men. The mean interval time between the last previous procedure 
and the actual operation was 7.8 ± 6.7 years (range, 0.17 to 22.9 years). Seven 
patients required an emergency operation. 
All patients underwent coronary angiography before reoperation, and in 8 patients 
preoperative coronary artery disease was characterized by angiographic evidence of 
significant (>50%) coronary stenosis or previous myocardial revascularization by 
coronary artery bypass grafting (CABG) or percutaneous coronary intervention. 
Patient characteristics are summarized in Table 1. 
Prior Operation on the Aortic Root 
The types of previous operation on the aortic root (the most recent in case of several 
previous operations) and concomitant procedures are listed in Table 2. Replacement 
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of the aortic valve and the aortic root was done in 42 patients (91%). The coronary 
ostia were reimplanted using the button technique in 91%. Two patients required a 
saphenous vein graft on right coronary artery. One patient had a Cabrol shunt for 
both coronary ostia and 1 patient for the right coronary ostium. 
Indication for Reoperation and Surgical Techniques 
The indications for reoperation are listed in Table 3. Aortic root replacement was 
the principal procedure in 39 patients (85%). Concomitant CABG was performed 
based on preoperative angiography in 4 patients. Table 4 describes the actual 
operative procedures performed. The technique for aortic root replacement and 
aortic arch replacement 
has been described 
previously [12, 13]. 
Briefly, a median 
sternotomy was 
performed. The common 
femoral artery (41%) or 
ascending aorta/aortic 
arch (46%) were usually 
used as arterial inflow, 
and the right atrium 
(directly or via the 
femoral vein using a 
double staged cannula) 
was used as venous site 
of drainage. In 10 
patients, 
cardiopulmonary bypass 
(CPB) was started before the reentry in the thorax, and in 4 patients, deep cooling 
(lowest rectal temperature was 19.5° ± 1.9°C) and a short period (range, 5 to 29 
minutes) of deep hypothermic circulatory arrest (DHCA) was actuated before 
resternotomy. We reserved to start CPB before resternotomy only in case of a 
minimal space between the aorta or the heart and the posterior aspect of the sternum 
as shown by chest imaging. In 5 patients, a false aneurysm ruptured during 
resternotomy, in 3 patients, the preoperative imaging assessment had led us to 
establish CPB before the reentry; however, the blood loss in all 5 patients was 
successfully managed without hemodynamic imbalance.
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Cardioplegia was administered selectively into the coronary ostia in 40 patients 
(87%) and was repeated when the ventricular septal temperature exceeded 10°C. 
Continuous topical cooling with cold Ringer’s acetate was used during the cardiac 
arrest. The left ventricle 
was vented through 
insertion of a cannula in 
the right upper 
pulmonary vein. In only 
1 patient cardiac 
cardioplegic arrest was 
not necessary because of 
closure of false 
aneurysm at an easily 
accessible site. Coronary 
reimplantation using the 
coronary button 
technique was planned in 
all patients. In 3 patients, 
however, the Cabrol 
extension was required. The first patient had already received a Cabrol shunt during 
a previous operation, the second patient required extension to the right coronary 
ostium as in a previous aortic root replacement, and the third patient presented with a 
proximal false aneurysm that involved the right coronary ostium, with extensive tissue 
destruction. 
Mean CPB time was 193 ± 50 minutes (range, 29 to 281 minutes), and the mean 
duration of aortic cross-clamping was 130 ± 36 minutes (range, 30 to 181 minutes). 
An open distal anastomosis was done in 17 patients. DHCA alone (lowest rectal 
temperature 19° ± 1°C) was used in 5 patients, with a mean duration of circulatory 
arrest of 28 ± 5 minutes (range, 23 to 35 minutes). DHCA with the adjunct of 
antegrade bilateral cerebral perfusion was established in 12 patients (lowest rectal 
temperature 22.5° ± 2.5°C) as described in previous reports [14]; in these cases, the 
mean duration in minutes of DHCA and of cerebral protection was, respectively, 54 
± 30 (range, 24 to 96) and 45 ± 28 (range, 19 to 94). 
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Statistical Analysis 
Continuous variables were 
expressed as the mean ± 2 
standard deviations. Univariate 
analysis (standard t test,  2, or 
Fisher exact test, when 
appropriate) included 22 
perioperative risk factors to 
determine whether any single 
variable influenced hospital mortality. These variables were sex, age, presence of 
Marfan syndrome, indication for prior operation, emergency status, presence of 
preoperative coronary artery disease, presence of chronic obstructive pulmonary 
disease, preoperative cerebrovascular accident, preoperative chronic renal failure, 
New York Heart Association functional class, left ventricular dysfunction, early 
reintervention, the number of previous operations, type of procedure; vascular graft, 
prosthetic valve, or valve infection; CPB time, cross-clamping time, postoperative 
revision for bleeding or tamponade, and postoperative renal failure, myocardial 
infarction (MI), cerebrovascular accident, and infection. 
Each variable with a value of p < 0.05 was entered in a multiple logistic regression 
analysis model to study its independent predictability. Survival rates and freedom 
from reoperation were calculated using the Kaplan-Meyer method. Statistical 
analyses were performed using the StatView 5.0 software (SAS Institute Inc, Cary, 
NC) and NCSS 2001 (Number Chruncher Statistical System, Kaysville, UT). 
Results 
Hospital Mortality 
There were no 
intraoperative deaths, but 3 
patients died before 
discharge, for an in-
hospital mortality rate of 
6.5%. The first patient was 
a 60-year-old man who had 
received an aortic root 
replacement with a 
prosthetic composite graft 
13 years before. He 
underwent reoperation for 
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a proximal false aneurysm, and an aortic valve replacement was also performed. He 
sustained a cardiac arrest on postoperative day 6 after an uneventful postoperative 
course. Emergency CPB was instituted. Despite adequate oral anticoagulation 
therapy and low-weight fractionated heparin, a massive thrombosis of the prosthetic 
valve involving both coronary ostia was found. After coronary revascularization, it 
was not possible to wean the patient from CPB. No coagulative disorders or heparin-
induced thrombocytopenia were identified. Postoperatively, the patient received 
low-molecular-weight fractionated heparin, acetyl salicyl acid, and warfarin. Factor 
VII was not administered. This incident remains unexplained for us. 
In the other 2 patients who died, preoperative prosthetic valve endocarditis had 
occurred. A postoperative MI in 1 patient resulted in low-output syndrome and 
sepsis. The other patient died of mediastinitis complicated by sepsis and multiorgan 
failure. 
The mean postoperative hospital stay was 17.9 ± 20.6 days and was significantly 
longer for patients with prosthetic endocarditis than for other root disease (35.6 ± 
29.8 vs 10.9 ± 9.1 days, p < 0.001). After univariate analysis, postoperative MI and 
postoperative renal failure were independent risk factors for hospital mortality. After 
logistic regression analysis, postoperative MI retained significance (p < 0.001). 
Hospital Morbidity 
The postoperative course was complicated in 19 patients (41%). Early reoperation 
was necessary in 8 patients, in 6 (13%) for excessive bleeding or tamponade and in 
2 (4.3%) for the removal of compress gauzes purposefully left in the thorax. 
Perioperative MI occurred in 2 patients (4.3%), cerebral stroke in 1 (2.1%) and 
transient ischemic attack in 4 (8.7%). Pulmonary infections occurred in 5 patients 
(10.8%) and postoperative sepsis in 2. We registered 1 patient with mediastinitis, 
and a permanent pacemaker implantation for complete AV block was necessary in 
6 (13%). 
Survival 
All patients were followed up at the outpatient clinic of our department or at 
peripheral sites. Mean follow-up time was 18 ± 22.5 months (range, 1 to 85 months) 
and was 100% complete. There were 3 late deaths. The cumulative survival rates 
(excluding hospital mortality) were 88% at 1 year and 74% at 5 years. The survival 
rates after operations for vascular or valvular prosthesis infection were 92% at 1 
year and 69% at 5 years. After operations for false aneurysm, we registered only one 
late operative death that accounted for an 89% survival rate at 1 and 5 years. The 
difference in survival between patients who underwent an operation for infection or 
false aneurysm (log-rank p _ 0.96) was not significant. 
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Freedom from reoperation (excluding early in-hospital operation for bleeding) on 
the aortic root was 100% at 1 year and 90% at 5 years, and freedom from reoperation 
on the ascending aorta and aortic root was 97% at 1 year and 70% at 5 years. Four 
other patients underwent further aortic procedures. In 2 patients a vascular 
endoprosthesis was placed in the descending thoracic aorta, and 2 patients 
underwent open thoracoabdominal aortic aneurysm repair. 
Comment 
Patients who have had previous aortic root operations may require reoperation for 
several indications. Although a first-time operation on the aortic root is performed 
routinely and with very low operative risk [3, 4], an operative mortality rate of up 
to 18% for reoperation has been reported [5–11]. Statistical analysis of previously 
published reports has identified a number of risk factors that contribute to poor 
outcome of this high-risk procedure. New York Heart Association functional class 
IV, age older than 75 years, chronic obstructive pulmonary disease, preoperative 
and postoperative renal dysfunction, coexisting coronary artery disease, CPB time, 
and urgent operation have all been shown to be predictors of death [5, 7, 10, 15, 16]. 
Interpretation of these studies is limited, however, because of the great variability 
in patient selection, such as differences in initial cardiac or aortic operations and 
reoperations. Some studies have included patients undergoing any type of proximal 
aortic procedure independently from the type of the previous cardiac operation [5, 
15, 16]. Other groups have reported their experience on aortic root reoperation after 
any type of previous cardiac operation [9, 17, 18] or only after aortic root procedures 
[6, 19, 20]. In the latter case, the series presented a small number of patients [19, 
20]. Joudinaud and colleagues [21] reported their experience in repeated operations 
for aortic homograft failure in a recent article. Table 5 summarizes the previously 
reported mortality rate and risk factors for mortality in patients undergoing a 
reoperation on the aortic root.Our study was undertaken to evaluate outcome and 
perioperative risk factors in a cohort of patients undergoing reoperation on the aortic 
root during a 7-year interval. Our results (in-hospital mortality rate of 6.5%) are 
encouraging considering the high complexity grade of the procedures performed, 
the emergency setting in 15% of the patients, and the indication of preoperative 
vascular or valvular infection in 35%. Raanani and colleagues [6] showed similar 
results, with an in-hospital mortality rate of 3.3% in 31 patients during a 20-year 
period. They were not able to identify any prognostic factor for mortality or 
morbidity. The indication for prior and redo operation in our series did not have 
significant prognostic value, confirming the results of Raanani and colleagues [6]. 
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Surprisingly, preoperative vascular or valvular infection does not have significant 
prognostic value on mortality or morbidity. It could be affected by the limited 
number of infectious patients in our series, the predominant choice for homograft or 
biologic composite grafts reimplantation in case of infection, and further by the strict 
6-week postoperative antibiotic regimen. Since the introduction of the biologic 
Bentall conduit, the 
popularity of the 
homograft 
decreased rapidly 
because of limited 
availability and 
severe calcification, 
despite similar 
results [22], 
explaining the 
limited number of 
homografts 
implanted. 
Each step of the 
reoperation should be assessed and properly prepared to decrease the incidence of 
severe problems. Previous reports [5, 17] showed the number of previous 
operations, technical problems during resternotomy, and an interval between 
operations of less than 8 months as significant risk factors for death at univariate 
analysis. A proper preoperative assessment is fundamental for achieving a safe 
reentry into the chest. A preoperative computed tomography (CT) scan is mandatory 
in every patient to delineate the relationship between the aorta, the true or false 
aneurysm, the heart, and the sternum. Besides a CT scan, a lateral chest 
roentgenogram should help to establish the presence of retrosternal space. Because 
of this strategy, already described and similar to that reported by other authors [10], 
we were prepared for high risk at reentry in those 5 patients in whom a rupture of 
the false aneurysm adherent to the posterior aspect of the sternum occurred. 
Myocardial protection is crucial for early outcome. Kirsch and colleagues [9] 
reported the need for unplanned CABG as significant risk factor for death. They 
documented “coronary problems” in 14 patients (25%). Half of these were linked to 
intraoperative and postoperative coronary malperfusion, and the early mortality rate 
for these patients was 70%. We prefer to deliver cold cardioplegia selectively into 
the coronary ostia, combined with continuous pericardial topical cooling while 
monitoring septal temperature, as mentioned before. In this setting, other authors 
suggested the use of retrograde cardioplegia [23] or continuous antegrade cold blood 
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cardioplegia delivered by a soft cannula inserted in the coronary ostia [6] to 
overcome the risk for insufficient cardioprotection. 
Multivariate analysis found that perioperative MI was the only variable that reached 
statistical significance as a risk factor for early death. However, in 1 of 2 patients, 
perioperative MI was a result of acute prosthetic valvular thrombosis. 
Unfortunately, cardiac enzymes were not routinely assessed in patients during their 
postoperative course. In patients undergoing CABG, troponin I was found to well 
characterize myocardial damage after cardiac arrest and emerged as predictor of 
early and midterm death from cardiac causes [24, 25]. A complete and systematic 
evaluation of myocardial damage through cardiac enzymes sample should guide 
postoperative care and myocardial protection strategy. 
The management of coronary flow reestablishment is still demanding, with a failure 
for coronary reimplantation of up to 25% to 50% [6, 9, 18]. In our experience (except 
in 2 patients in whom a Cabrol was performed at the prior operation), we were forced 
to a graft elongation to the coronary ostia in only 1 patient, even if graft infection 
and false aneurysm were found in 70% of patients. In only 1 patient did we perform 
myocardial revascularization with a venous graft on the right coronary artery for 
intraoperative right ventricular failure, resulting in an uncomplicated postoperative 
course. 
For a degenerative aneurysm, axillary artery cannulation may be the site of choice. 
This strategy could allow a lower risk of preoperative stroke and could be associated 
with a lower mortality rate [26]. In our experience, however, femoral artery 
cannulation was performed safely. 
Preparation of the aortic root in a reoperation is a demanding and precise job. In our 
experience, direct injury of the pulmonary artery or trunk is a rare problem that is 
usually immediately recognized and oversewn. One patient, however, required 
reoperation 8 months after the root procedure for a false aneurysm of the right 
pulmonary artery, which was repaired with a patch plasty. 
Although redo interventions on the aortic root can be performed with a low rate of 
operative technical problems and encouraging early survival, the postoperative 
morbidity rate is high. At least one major complication occurred in 19 (41%) 
patients, and 6 (13%) required early reoperations for excessive bleeding or 
tamponade. Six (13%) needed implantation of a permanent pacemaker for complete 
AV block, which is in the same range as described by Kirsch (9%) [9] and by 
Raanani (18%) [6]. 
Cerebrovascular accidents occurred in 5 patients and were transient or reversible in 
4. Two of the 12 patients who underwent DHCA and antegrade bilateral cerebral 
perfusion sustained transient cerebrovascular accidents. This was a higher rate than 
that reported in our previous experience [14]; however, these patients had associated 
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further risk factors, including the aortic procedure itself, the emergency setting, and 
previous cerebral vascular accident. One patient who required a repeated period of 
DHCA because of uncontrollable bleeding from a distal prosthesis suture sustained 
a stroke, with partial functional recovery. 
Intensive outpatient clinic follow-up is mandatory for these patients. The need for 
continued long-term cardiovascular surveillance is accentuated by the fact that 9 of 
our patients needed a reintervention 15 years after the primary one. The mean 
interval of 7.8 years between the two interventions illustrates that patients remain at 
risk for later development of complications that require new repair, even if the first 
repair was a radical one. This warrants annual examination by the cardiologist or 
cardiovascular surgeon with echocardiography, CT scan, or magnetic resonance 
imaging. 
The survival in our study at 1 year and 5 years of 88% and 74% is similar to the 
93% and 71% reported in the Toronto General Hospital experience [6]. A worse 
outcome was reported by Kirsch [9] of 73% at 1 year and 66% at 5 years, but this 
was a cumulative survival including all three cohorts of their study and presenting 
25% of patients with moderate to severe left ventricular dysfunction. 
Reoperation on the aortic root is still a complex procedure that necessitates an 
extensive preoperative workup. Early and late survival and freedom from 
reoperation are good, but the postoperative course is characterized by a high 
morbidity rate. Perioperative MI is a significant predictor for early death. 
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Abstract 
Background. Human allografts and pulmonary autografts offer many advantages 
as an aortic valve and root substitute. The progressive degeneration of the aortic 
allograft and the pulmonary autograft has been seen as an important disadvantage, 
and the need for a reoperation has been perceived as challenging and risky for the 
patients. 
Methods. Between March 1992 and October 2009, 53 consecutive patients (mean 
age 50 ± 13 years; 38 male), who had a previous aortic root replacement, underwent 
redo surgery for failure of the aortic homograft (n = 42) or the pulmonary autograft 
(n = 11). The median follow- up (available for 47 of 51 patients) was 44 months.
Results. Structural valve deterioration was the main indication for reoperation on 
the homograft (86%), with an earlier presentation in patients who received 
homografts from donors more than 55 years old. Failure of the pulmonary autograft 
occurred primarily because of severe aortic regurgitation predominantly due to 
dilation of the autograft (n = 5) and autograft valve prolapse (n = 5). The total in-
hospital mortality was 3.8% (n = 2). No deaths occurred among patients who 
previously underwent a Ross procedure. The course was complicated in 25 cases 
(48%). The cumulative 1-year, 5-year, and 8-year survival rates were 92%, 90%, 
and 77%, respectively. No late deaths were encountered after reoperation on the 
pulmonary autograft (maximum follow-up 218 months). Freedom from reoperation 
(excluding early in-hospital operation) for recurrent aortic valve or root pathology 
was 97% at 8 years. 
Conclusions. Reoperation after freestanding homograft and pulmonary autograft 
root replacement can be accomplished safely. The total postoperative morbidity rate 
is still high. 
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Human allografts and pulmonary autografts offer many advantages as aortic valve 
and root substitutes. The use of aortic homografts has been limited by the lack of 
availability and the complexity of insertion, whereas the Ross operation, even if 
widely performed, is considered to be the treatment of choice for aortic valve disease 
in children and a surgical alternative in selected young adults. Many patients require 
a reoperation owing to the limited durability of the aortic homograft, despite 
superior hemodynamics in restoring normal flow in the aortic root, sinuses, and 
coronary ostia, and despite the freedom from thromboembolism and a better 
resistance to infections [1, 2]. The rate of deterioration is dependent on the patient’s 
age, implantation technique, source of homograft, and the sterilization and 
preservation method [2, 3]. Homograft dysfunction may also be due to infection and, 
rarely, false aneurysms may occur. The pulmonary autografts show a stable 
behaviour regarding transvalvular gradients and a low incidence of infective or 
thromboembolic events. Patients may, however, require a reoperation because of 
autograft failure due to the development of an autograft aneurysm or severe aortic 
regurgitation at longer follow-up [4, 5]. Reoperation on the aortic root after aortic 
homograft implantation are demanding for the surgeon and high risk for the patients 
because of tissue degeneration, the possible infectious lesions, calcification of the 
homograft wall, and periconduit adhesions [6, 7]. 
We present our experience with aortic valve and root reoperations after homograft 
implantations and Ross procedures. We describe the surgical strategies, 
intraoperative and postoperative events, and midterm results. 
Patients and Methods 
Patient Population 
Between March 1992 and October 2009, 53 consecutive patients who had a previous 
aortic root replacement underwent redo surgery for failure of the aortic homograft 
(n = 42) or the pulmonary autograft (n = 11) at the Cardio-Thoracic Department of 
the St. Antonius Hospital, Nieuwegein, The Netherlands. The Local Ethical 
Committee approved the study and waived the need for patient consent. The mean 
age of the patients at the time of reoperation was 50 ± 13 years (range, 18 to 79 
years), and 38 (72%) were male. The mean interval time between the initial 
procedure and the actual (redo) operation was 8.5 ± 5.4 years (range, 0.1 to 24). Six 
patients had preoperative coronary artery disease characterized by angiographic 
evidence of significant (>50%) coronary stenosis or by a previous history of 
myocardial revascularization (coronary artery bypass graft surgery [CABG] or 
percutaneous coronary intervention). The median follow-up (available for 47 of 51 
patients) was 44 months. The patient characteristics are shown in Table 1. 
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Prior Operation Performed
Twenty-six patients 
underwent the first 
operation at the St. Antonius 
Hospital. Freestanding 
aortic root replacement with 
homograft implantation was 
performed in 42 patients. 
The operating technique has 
been described previously 
[8, 9]. A concomitant 
procedure was performed in 
6 patients: mitral valve 
replacement (n = 2), 
tricuspid valve repair (n = 
1), CABG (n = 1), atrial 
septal defect closure (n = 1), and complete ascending aorta replacement (n = 1). Four 
patients had already undergone a redo operation (CABG, n = 1; reoperation for false 
aneurysm, n = 2; ascending aorta and arch replacement for aortic dissection, n = 1) 
before the reoperation on the homograft. In 23 cases (43%), the indication for the 
initial operation was valve endocarditis. All cryopreserved homografts were 
provided by Bio Implant Service Foundation (BIS Foundation, Leiden, The 
Netherlands). The donor age was available for 34 of the 42 patients who received a 
prior freestanding root homograft. The donors had a mean age of 50 ± 9 years (range, 
28 to 67 years). In light of previously published evidence on risk factors for 
homograft degeneration [2], we observed that in only 1 case was the donor age over 
65 years. The mean absolute donor-patient age difference was 7.5 ± 16 years. The 
real age difference was more than 25 years in 1 patient, between 24 and 10 years in 
6, and between 9 and 10 years in 11 patients. Twelve patients were 11 to 25 years 
older than the donor, and 4 patients more than 25 years.  
Eleven patients underwent pulmonary autograft root replacement and right 
ventricular outflow tract reconstruction with a cryopreserved pulmonary homograft 
[10, 11]. The technique of pulmonary autograft harvesting and preparation has been 
described previously [10, 11]. Briefly, the autograft was implanted as a freestanding 
root in all patients. The diameters of the pulmonary autograft and the aortic annulus 
were assessed by intraoperative measurement using cylindrical sizers. If required, 
the proximal autograft suture line was reinforced using a 5-mm strip of a woven 
Dacron (C.R. Bard, Haverhill, PA), Teflon felt (Impra Inc, subsidiary of C.R. Bard, 
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Temple, AZ), or fresh autologous pericardium. Aortic annulus reduction was carried 
out if necessary, by placing two 2-0 polypropylene sutures as a purse-string in a 
single horizontal plane just below the aortic annulus. 
Indication for 
Reoperation and 
Surgical Technique 
The indications for a 
reoperation were 
homograft structural 
valve deterioration 
(SVD), infective 
endocarditis (IE), and 
technical failure (TF), as 
reported by Nowicki and 
coworkers [12]. 
Pulmonary autograft 
failure was defined as the 
presence of severe aortic 
regurgitation due to 
autograft valve prolapse and or autograft dilation (>50 mm). Aortic root replacement 
was the most common procedure performed (28 patients, 53%). Table 2 describes 
the actual operative procedures performed.  
A median sternotomy was performed in all patients. We reserved the start of CPB 
before resternotomy only in case of minimal space (less than 2 cm) between the 
aorta or the heart and the posterior aspect of the sternum as shown by chest imaging. 
Two patients underwent deep cooling and a short period of deep hypothermic 
circulatory arrest before resternotomy. Cardiopulmonary bypass (CPB) was 
established using the ascending aorta (77%) or femoral artery (21%) as the arterial 
inflow site and the right atrium as the venous drainage site. Cardioplegia was usually 
administered selectively into the coronary ostia in case of aortic valve regurgitation 
and repeated if the ventricular septal temperature exceeded 10°C. Continuous 
topical cooling with cold Ringer’s lactate was used during cardiac arrest. The left 
ventricle was vented through the right superior pulmonary vein.  
The decision for root or valve replacement was made during the operation 
depending on the presence of root dilation. In patients who underwent a re-
replacement of the aortic root, the homograft or autograft was dissected with 
electrical cauterization and removed sparing the coronary buttons, which were 
separated using a scalpel. We were able to reestablish the native flow into the 
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coronary ostia in all cases. No graft elongation to coronary artery was needed. In 1 
patient who underwent redo aortic valve replacement, we were forced to perform 
myocardial revascularization with a single saphenous vein graft to the right coronary 
artery. Mean CPB time was 166 ± 77 minutes (range, 65 to 502 minutes), and the 
mean duration of aortic cross-clamping time was 116 ± 62 minutes (range, 43 to 388 
minutes). Antegrade selective cerebral perfusion was used in 4 patients for 
construction of an open distal anastomosis. 
Statistical Analysis 
Continuous variables are presented as the mean ± SD. Twelve perioperative variable 
were entered into an univariate analysis (standard Student’s t test, 2, or Fisher’s 
exact test when appropriate) to determine influence on the hospital mortality and 
morbidity. These variables were sex, age, etiology, presence of preoperative 
coronary artery disease, left ventricular dysfunction, number of previous operations 
requiring opening of the pericardium, CPB time, cross-clamping time, 
reintervention for bleeding or tamponade, postoperative renal failure, perioperative 
myocardial infarction, and postoperative infection. Survival rates and freedom from 
reoperation were calculated using the Kaplan-Meyer method. Statistical analyses 
were performed using the StatView 5.0 software (SAS Institute, Cary, NC) and 
Number Cruncher Statistical System 2001 (NCSS, Kaysville, UT). 
Results 
Indication for Reoperation and Surgical Procedures 
HOMOGRAFT. The most common indication for reoperation was SVD (36 
patients, 86%); in 2 cases, it was associated with the occurrence of a false aneurysm. 
Reoperation for TF (false aneurysm in all cases) accounted for 3 patients (7%). 
Endocarditis was present in 3 cases (7%). There was no statistical difference in 
interval between prior and reoperation according to the etiology (TF + IE versus 
SVD, 5.7 ± 5.6 years versus 9.2 ± 4.6 years; p = 0.1). 
In patients who had a donor-patient age difference more than 10 years, SVD showed 
an earlier presentation but donor-patient age difference did not retain statistical 
significance (interval time between operation donor-patient age difference <[10] 
versus donor-patient age difference >[10], 10.4 ± 4.7 years versus 8.4 ± 5.1 years: p 
= 0.3). Homografts from donors more than 55 years old showed earlier SVD with a 
significant difference in time interval for reoperation (donor’s age >55 years versus 
donor’s age <55 years: 4.5 ± 3.5 years versus 10.6 ± 4.5 years; p = 0.005; Fig 1). 
Structural valve deterioration presented as aortic regurgitation or mixed 
regurgitation and stenosis in 31 patients (86%); pure stenosis was found in 5 cases 
87 
(14%). In all cases, tears and calcification of the cusps were found, and 7 patients 
had a completely calcified homograft (valve and arterial wall). 
No difference in mortality was found among patients undergoing complete re-root 
procedure (n = 23) or isolated aortic valve re-replacement (AVR [n = 19]) according 
to indication, homografts’ lesions, and age. Patients undergoing re-root replacement 
had a more extensive procedure with involvement of the entire ascending aorta and 
the aortic arch, and obviously had longer CPB and cross-clamp times. Aortic valve 
rereplacement versus re-root CPB time was 114 ± 35 minutes versus 228 ± 80 
minutes (p < 0.01), respectively; and cross-clamp time was 73 ± 23 minutes versus 
157 ± 69 minutes (p < 0.01), respectively. 
PULMONARY AUTOGRAFT. Failure of the pulmonary autograft occurred 
primarily because of severe aortic regurgitation predominantly due to autograft 
valve prolapse (n = 5) and dilation of the autograft (n = 5). One patient presented 
with isolated autograft dilation. In the latter 6 cases, we reserved aortic root re-
replacement. Concomitant aortic procedures (replacement of ascending aorta, n = 5; 
aortic arch replacement, n = 1) were performed in 6 patients, and 1 patient had a 
mitral valve repair and a tricuspid valve repair. The median time interval between 
the operations was 6 years, whereas 2 patients had an early reoperation in the first 
postoperative year because of severe aortic insufficiency treated by an aortic valve 
replacement with a mechanical prosthesis. 
Hospital Mortality
The global in-hospital 
mortality was 3.8% (n = 
2). There was one 
intraoperative death 
due to unsuccessful 
weaning from CPB. A 
49-year-old man who 
had undergone aortic 
root replacement with a homograft 7 years earlier was reoperated on for endocarditis 
and a Shelhigh Bio-Conduit (Shelhigh, Milburn, NJ) was implanted; a single CABG 
on the right coronary artery and a tricuspid valve repair were also performed. He 
had prolonged CPB and cross-clamp times with difficult hemostasis that required 
intentional closure on gauzes. The postoperative course was complicated by 
prolonged intubation and death due to multiorgan failure. 
The patients who received a prior pulmonary autograft had no in-hospital mortality 
after the reoperation. The univariate analysis revealed history of coronary artery 
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disease and previous homograft implantation as a significant risk factors for hospital 
mortality (p < 0.001). 
Hospital Morbidity 
The course was complicated in 25 cases (48%). Early reoperation for excessive 
bleeding or tamponade (n = 7, 13.4%) and for the removal of gauzes intentionally 
left in the thorax (n = 3, 5.7%) was necessary in 10 patients. 
Perioperative myocardial infarction occurred in 4 patients (7.7%). Two patients had 
postoperative sepsis (3.8%). In 4 cases (7.7%), a permanent pacemaker implantation 
was necessary for complete atrioventricular block. Age more than 60 years was a 
significant risk factor for the occurrence of at least one major postoperative 
complication not including death by univariate analysis (p = 0.05). No statistical 
differences were found between patients who underwent complex root and aortic 
procedure and patients who had isolated AVR. Patients who underwent reoperation 
for a previous homograft or pulmonary autograft had a similar complication rate. 
The median postoperative intensive care unit stay was 48 hours. The median 
postoperative hospital stay was 11 days. 
Survival 
All patients were followed up at the outpatient clinic of our department or at 
peripheral hospitals. Median follow-up time was 44 months (range, 1 to 218), and it 
was available for 47 of the 51 patients discharged from the hospital. There were 3 
early deaths (<12 months) and 2 late deaths. The cumulative 1-year, 5-year, and 8-
year survival rates were, respectively, 92%, 90%, and 77%. Survival after 
reoperation on the homograft at 1 year, 5 years, and 8 years was 90%, 86%, and 
70%, respectively. No late deaths were encountered after reoperation on the 
pulmonary autograft (maximum follow-up 218 months).
Freedom from reoperation (excluding early in-hospital operation) for recurrent 
aortic valve or root pathology was 97% at 8 years. No difference was found in 
survival and freedom from reoperation according to redo operation performed. 
Comment 
Aortic homograft and pulmonary autograft offer many hemodynamic advantages in 
restoration of the blood flow into the aortic root, sinuses and coronary ostia. This 
advantage is translated in transvalvular gradients that are lower than in other aortic 
substitutes, and furthermore, a more complete regression of the left ventricular 
hypertrophy is observed [13, 14]. 
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Even though the lack of availability of the homograft, the complexity of, and the 
strict indication for the Ross operation [5, 15] have limited the widespread of these 
procedures, several papers in the literature have reported excellent in-hospital and 
long-term outcomes [2, 5, 9, 11, 14–20]. Despite these encouraging results, the 
progressive degeneration of the aortic allograft and the pulmonary autograft has 
been seen as an important disadvantage, and the need for a reoperation has been 
perceived as challenging and very risky for the patients. 
Homograft 
Aortic homografts have shown a progressive loss of their cellular components and 
normal tissue architecture soon after implantation with almost acellular tissue after 
1 year. There is no evidence of immune-mediated injuries on cryopreserved 
allografts, probably due to severe reduction or absence of the donor’s endothelium. 
However, a low-grade inflammatory response has been observed. These finding are 
reported in homografts explanted both for severe degeneration or for technical 
problems [21]. 
Rising donor age and rising donor-patient age difference were observed as risk 
factors for tissue failure [2]. Our analysis shows a significantly shorter time between 
homograft implantation and reoperation for SVD in donors aged more than 55 years. 
Earlier presentation of SVD is seen when the donor-patient age mismatch is longer 
than 10 years. One could speculate that this trend might be significant in a larger 
cohort of patients. Furthermore, the time interval tends to be shorter when a 
reoperation is needed for TF (including false aneurysm) and IE than for SVD. 
Nowicki and associates [12] have already described the occurrence of a false 
aneurysm and endocarditis as predictors for an earlier reoperation on the homograft. 
Patients with SVD presented mainly with mixed aortic regurgitation and stenosis 
(86%). Macroscopic examination revealed thickening of the leaflets with focal or 
extensive calcification in all the cases. In 7 cases, we observed a completely 
calcified homograft, representing the technically more challenging subset of 
patients. In accordance with previous reports [6, 7], we performed a re-root 
replacement in these cases with a valve conduit to allow an easier implantation with 
satisfying annular sealing and avoiding potential patient prosthesis mismatch due to 
valve downsizing. The presence of infective endocarditis or an aortic false aneurysm 
is important for determining the perioperative surgical strategy [1, 12]. In these 
cases, the decision to perform a redo AVR or a re-root replacement was based on 
intraoperative evaluation whether root dilation or destruction was present. 
As in our previous experience [22], we were not able to find differences in 
postoperative mortality and morbidity based on the etiology (IE versus TF/SVD). 
That could be explained by the high SVD rate (86%), with only 3 cases of IE and 3 
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cases of false aneurysm. Furthermore, the outcome was not affected by the extent 
of surgery (valve or root replacement). 
The choice for a mechanical or bioprosthesis was made according to the clinical 
presentation and the patient’s profile to ensure adequate prosthesis durability and 
avoiding yet another operation in the future. A mechanical prosthesis was chosen 
for younger patients whereas a biologic prosthesis was implanted in older patients, 
and showed similar results compared with aortic allografts, especially for IE [23]. 
Our data suggest that a reoperation after freestanding homograft implantation, 
although technically demanding, is feasible and relatively safe. The 30-day 
mortality was 3.8%, which is in the same range as reported in the literature, ranging 
from 0% to 11% [1, 6, 7, 12, 24, 25]. 
Our postoperative morbidity rate is high, with the occurrence of at least one major 
complication in half of the patients. The incidence of an early reoperation was 8 of 
41 patients for bleeding or tamponade. This finding may be explained by our not 
tolerating prolonged bleeding to avoid excessive transfusion and hemodynamic 
imbalance. Postoperative cerebral stroke has a low incidence in our cohort (1 of 41 
patients) in spite of the presence of calcification, fibrosis, and frail tissue, and 
confirms data from previous papers [6, 25]. 
Pulmonary Autograft 
Valve thickness, especially on the ventricular surface, a severe loss of rich elastin 
media, and a delicate adventitia with media smooth muscle cells hypertrophy and 
an increase in collagen are recognized as pathologic changes in explanted 
pulmonary autografts [26]. Dilation and regurgitation are the primary causes of 
pulmonary autograft failure and the principal reason for a reoperation after a Ross 
procedure. A recent paper by de Kerchove and colleagues [4] suggests that late 
aortic insufficiency developed depending on the technique of implantation. 
They reported that autograft dilation occurred predominantly in patients who had 
undergone a complete root replacement, whereas autograft valve prolapse was 
observed after a valve substitution with inclusion technique. The revised experience 
with the Ross operation at the Toronto General Hospital did not reveal a definite 
role of the operating technique in late dilation and eventual failure of the pulmonary 
autograft [5]. Apart from the surgical technique, male sex [5, 15, 20], preoperative 
aortic insufficiency [5, 15], and aortic annulus size above 27 mm [5] are associated 
with a higher probability of reoperation on the pulmonary autograft and late 
postoperative aortic regurgitation. Our data show a low morbidity rate and 100% 
survival and freedom from reoperation after a median follow-up of 5 years, better 
than reported in the literature [5, 27-29]. 
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Experience with repairing the failing pulmonary autograft is limited. From 2001 to 
2009, 28 procedures have been described in the literature, with the longest follow-
up of 3.2 ± 1.5 years [29]. The preservation of a failing pulmonary autograft could 
be effectively treated by a David valve-sparing root replacement [27]. In contrast, 
the Yacoub procedure could have the disadvantage of not allowing stabilization of 
the annulus [29]. To prevent the risk of another reoperation in the future, we 
preferred to perform a valve or root replacement in all the patients. Based on their 
age, for 10 of 11 patients, we used a mechanical prosthesis. Owing to the primary 
purpose of reviewing our experience in aortic reoperation, we have not proposed 
and discussed reoperations for failing homografts in the pulmonary position. 
In conclusion, a prior homograft or pulmonary autograft implantation may result in 
a reoperation during long-term follow-up. Reentry for a new aortic valve or root 
procedure could be perceived as high risk for the patient and technically demanding 
for the surgeon. Our study shows a safe outcome after these complex operations in 
spite of a high rate of global postoperative morbidity. The management of homograft 
degeneration, especially in the presence of a complete calcified valve and vascular 
wall, is still challenging. Homografts have been shown to be resistant to IE, but the 
introduction of bioconduits is emerging as a valid and durable alternative, with a 
lower rate of degeneration and easier redo approach. The pulmonary autograft in the 
adult has been shown to have a lower rate of failure in female patients, in cases of 
aortic stenosis, and in less dilated aortic annulus (less than 27 mm). This evidence 
should be taken into account while proposing a Ross procedure to avoid an operation 
that, so to speak, “solves a single valve problem by creating a double-valve problem 
in the long run” [30]. 
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Abstract 
Background. Our objective was to analyze the causes, timing and results of 
reoperation after primary 
repair for acute type A dissection. 
Methods. 104 consecutive patients underwent a reoperation after previous type A 
aortic dissection repair (1972–2008). Supracoronary ascending aorta replacement 
(SCAR) was commonly performed during primary repair and it was associated with 
aortic root replacement in 13 cases and with (hemi)arch replacement in 26 patients. 
Progression of aortic dilatation was seen in 91 patients (87%), aortic regurgitation 
in 21 (20%) and false aneurysm in 15 patients (14%). A redo Bentall procedure was 
performed in 34 cases, arch replacement in 42 patients and thoracoabdominal aorta 
replacement in 20 patients. The median follow-up was 6.5 years (range 0.3–23.8 
years). 
Results. The in-hospital mortality after redo surgery was 7.7%. The global survival 
rate at 1-, 5- and 10-year was 92%, 82% and 58% respectively. Proximal 
reoperations were more frequent in patients who had SCAR and flap extension into 
the aortic root. Patients with an unresected intimal tear and distal extension of 
dissection flap experienced a higher rate of aortic arch and thoracoabdominal aorta 
redo procedures. 
Conclusions. More extensive acute dissection repair results in a lower rate of 
reoperation. Mortality for redo surgery after type A acute dissection repair is 
acceptable. This finding should be taken into account in proposing a wide spread of 
more complex and extensive surgery for type A acute dissection. 
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In-hospital survival is the primary objective in patients with type A acute aortic 
dissection. Exclusion of the intimal tear and reapproximation of the aortic layers 
form the basis of the surgical repair and is associated with an acceptable mortality 
rate [1-3]. 
Several mechanisms of pathological evolution are responsible for the necessity of 
reoperations in the future: progressive aortic valve regurgitation [4], progressive 
dilatation of a preserved aortic root [5] and of non-resected distal segments of the 
native aorta [6,7] and false aneurysms’ development [1]. More extensive surgery 
seems to be protective in preventing future reoperations, however it could be 
burdened by a higher mortality and morbidity rate [1,3]. The debate about the 
suitability and effectiveness of less or more radical procedures in the acute setting 
is still open. 
We investigate the causes for reoperation, the surgical indication, the timing of redo 
surgery and aortic segments’ involvement during redo procedures after type A acute 
aortic dissection repair. 
Patients and Methods 
Patient population 
In the period 1972 – 2008, 592 patients were operated for type A acute aortic 
dissection at the St. Antonius Hospital, Nieuwegein, Netherlands; 104 of these 
patients underwent an aortic reoperation and represent the study population. The 
Local Ethics Committee approved the study and waived the need for patient consent. 
All data were retrospectively collected from patient files. The mean age of the 
patients at the time of reoperation was 61 ± 12 years (range 26 – 80 years) and 80 
(77%) patients were male. Eight (7.7%) patients had Marfan syndrome. The median 
follow-up was 6.5 years (range 0.3 – 23.8 years). 
Acute dissection repairTable 1 showed the site of the intimal tear and the data about 
proximal and distal extension of the intimal flap as witnessed by intraoperative 
findings or preoperative imaging.The aortic dissection repair protocol 
comprehended arterial groin cannulation often before sternotomy, venous drainage 
from the right atrium and left ventricular venting through the right upper pulmonary 
vein. Axillary artery cannulation was not used.
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Supracoronary ascending aorta replacement (SCAR) was performed in 102 patients, 
proximal repair included resuspension of the aortic valve (fixation of the aortic 
commissures to the aortic 
adventitial layer) in 48 
patients (46%), aortic valve 
replacement in 6 cases (6%) 
and aortic root replacement 
in 13 patients (11 Bentall, 2 
David reimplantation; 12%); 
two patients had resection of 
the intimal tear followed by a 
direct aortic end-to-end 
anastomosis. 
A distal anastomosis made 
on cross clamp was common 
in the early years. More 
recently, an open distal 
anastomosis was performed 
either after cross clamping 
with subsequent clamping 
zone excision either after 
direct opening of the aorta under hypothermic conditions (74 patients, 71%): 38 
patients underwent selective antegrade cerebral perfusion (54±19 minutes) at rectal 
temperature of 25°C degrees; 36 patients had deep hypothermic circulatory arrest 
(18°-20°C degrees, flat EEG) without adjunctive cerebral protection. Distal repair 
included in 26 cases (25%), an aortic (hemi)arch replacement. Strips of felt were 
used in 68% of the patients. GRF glue was used in 60% of the patients (57/95) in 
the time period 1985 to 1999, while in 29% (22/75 patients) human fibrin glue was 
adjusted as a sealant on the external suture line. 
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Indication and type of reoperation 
Table 2 shows data about indication and site (proximal or distal) of reoperation. The 
technique for replacement of the aortic root, aortic arch, descending and 
thoracoabdominal aorta, as well as the strategy for a safe chest re-entry has been 
described previously [8-11]. Table 3 describes the actual operative procedures 
performed. 
Statistical analysis 
Continuous variables 
were expressed as the 
mean +/- SD. Standard 
Student’s t test, chi square 
or Fisher’s exact test 
(variables: acute 
dissection repair, flap 
extension, unresected 
intimal tear, distal 
anastomosis, glues, felts) 
were used appropriately 
for univariate analysis. 
Survival rates and 
freedom from reoperation 
were calculated using the 
Kaplan-Meyer method. 
Statistical analyses were 
performed using the Stat-
View Statistical Software 
Package 5.0 (SAS 
Institute, Inc. Cary, NC), 
NCSS 2001 (Number 
Cruncher Statistical 
System, Kaysville, Utah). 
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Results 
Interval between acute dissection repair and re-operation 
The interval between the primary operation and reoperation was 5.2 ± 5.3 years 
(range 0.1 – 29.3 years). There was no difference in interval time according to 
different indications for redo surgery: false aneurysm (A), post-dissection aortic 
dilatation (B), aortic regurgitation (C) (5.2 ± 7 years, 5.3 ± 4.8 years, 5.7 ± 4.9 years; 
A vs. B p= 0.97; A vs. C p=0.73; B vs. C p=0.74). In patients re-operated for 
endocarditis (D), the interval time was significantly shorter with a mean of 1.7 ± 2 
years (A+B+C vs. D, p= 0.04). 
In-hospital mortality and survival 
The overall in-hospital mortality was 7.7% (8/104 patients). It was higher for 
patients presenting with a false aneurysm (3/14, 21%) or infective endocarditis (2/7, 
28%) (5/21 vs. 3/83 of remaining patients, p=0.008). 
During the follow-up period, we registered 31 deaths. In at least 15 cases, the cause 
was not related to the aortic dissection or to a late complication of the re-operation 
(4 patients had worsened heart failure and eleven had pulmonary, cerebral or liver 
disease). The global survival rate was 92%, 82% and 58% at 1-, 5-, and 10-years 
respectively. 
Further reoperations 
Eighteen patients underwent a third operation after acute dissection repair. The main 
indication was a false aneurysm in 4 patients, endocarditis in two cases, root 
dilatation and aortic regurgitation in one patient and in the remaining cases the 
development of a post-dissection aneurysm. One in-hospital death was observed. 
Among these patients the survival rate at 1-,5-,and 10-year was 92%, 85% and 69% 
respectively. 
Further re-operations were necessary in five patients for a global of seven 
procedures (correction of a false aneurysm in two cases, arch replacement in one 
case and four step-wise procedures for replacement of the thoracic and 
thoracoabdominal aorta). No hospital death was observed. 
Proximal reoperations 
Patients who initially had aortic root or valve replacement experienced a lower rate 
of proximal redo procedures compared to patients who received initially isolated 
SCAR (4/19 vs. 40/85; p=0.057). A significant difference was found in patients who 
had flap extension into the aortic root (76 patients): 32/61 patients with SCAR 
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underwent proximal reoperations vs. 3/15 patients with previous root/AVR 
(p=0.04). 
Patients who had SCAR without flap root involvement experienced a lower rate of 
proximal procedures at the reoperation than patients with a dissected root (3/17 vs. 
32/61 patients respectively; p=0.02). 
Twenty-nine patients who had aortic valve resuspension in the acute setting 
underwent a re-root/AVR procedure (29/48, 60%). This finding was not dependent 
from the degree of aortic regurgitation before dissection repair (moderate to severe 
5/8 patients vs. none to mild 24/40 patients, p=0.79). 
Restoring the geometry of the sinotubular junction without valve resuspension 
showed apparently a lower rate of proximal reoperation than resuspension itself: 
11/37 patients vs. 29/48 patients respectively (p= 0.009). After stratification for the 
presence of flap extension into the aortic root, no difference in terms of re-root/AVR 
procedures was found between these two groups (7/19 vs. 25/42; p=0.1). 
Distal reoperations: aortic arch 
Thirty-one patients (40%) who did not received (hemi)arch replacement during 
acute dissection repair underwent aortic arch surgery at the reoperation. 
Patients with limited flap extension to the proximal aortic arch had a tendency in 
lower rate of arch redo procedure vs. patients with full arch (2/16 vs. 16/36,p=0.05) 
or cerebral vessels involvement (2/16 vs. 6/12,p=0.07). 
Patients with an unresected intimal tear (9 cases, all repairs performed before 1999) 
had a higher rate of reoperation for arch replacement (6/9 vs. 15/55, p=0.05). 
Creation of an open distal anastomosis resulted in a lower rate of reoperation for 
false aneurysm of the distal suture line: 4/74 vs. 5/30 in patients who had the distal 
anastomosis on cross clamp suture (p=0.06). 
Distal reoperations: descending, thoracoabdominal and abdominal aorta 
Thirty six patients (50%; data available for 72 patients) had flap extension to the 
descending or thoracoabdominal aorta. These patients had a reoperation for post-
dissection aneurysm in seventeen cases (17/36 vs. 13/36 in patients without flap 
extension, p=0.33) and further distal reoperations for a global amount of 25 
procedures.(vs. 14/36 without flap extension, p=0.009). There was only one patient 
diagnosed with a main entry in the descending aorta, he underwent reoperation for 
thoracoabdominal aneurysm. 
Glues and felts 
The occurrence of aortic false aneurysm or anastomosis disruption was studied 
according to the use of glues and the use of felts strips at every single anastomosis. 
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We did not observe any difference in rate of anastomosis reinforcement with or 
without felt as well as for the usage of GRF or human fibrin glues. 
Comment 
The primary goal in treating patients with acute type A dissection is avoiding aortic 
rupture, cardiac tamponade and to solve dissection related malperfusion. Several 
papers analysing in-hospital outcome and late survival have focused on safety and 
effectiveness in performing a SCAR and reapproximation of the aortic layers with 
or without aortic valve resuspension [12,13]. However, this strategy certainly leaves 
many patients at risk for future reoperations. For this reason close and regular 
clinical and imaging follow-up is fundamental to check the development of post-
dissection aneurysms, severe aortic regurgitation and aortic false aneurysms [11,14]. 
The well documented development of cerebral protection techniques [15,16] 
nowadays leads surgeons to be more aggressive towards arch replacement with a 
more liberal use of an elephant trunk irrespective of the localisation of the intimal 
tear [17]. Similarly, some studies have reported encouraging results with a more 
radical approach in treating proximal disease of acute aortic dissection by (valve-
sparing or not) aortic root replacement [5,18] in order to prevent future reoperations. 
This paper presents the largest series in literature on reoperations after type A 
dissection repair. The registered mortality was acceptable considering the technical 
challenges, the systemic trauma, the type of lesions and the quality of the tissue. 
These results confirm the few reports in literature on reoperations after type A 
dissection repair with an in-hospital mortality ranging from 0% to 12% [19-23]. 
The long-term survival rate is encouraging and it is not surprising that patients who 
had initially and/or subsequently more extensive surgery had better a long-term 
outcome and no mortality related to aortic pathology. Anyway we are definitely 
convinced that a tailored approach addressing and respecting patients’ 
characteristics and the clinical presentation, is requested to guarantee the best 
outcome and freedom from reoperation. 
Proximal repair and reoperations 
In type A dissection aortic regurgitation usually develops in a functionally normal 
valve as a consequence of the proximal extension of the dissection. Total root 
replacement is indicated in case of root dilatation [5,24], extensive root destruction 
[24], in presence of an intimal tear located in the aortic root or coronary ostia or in 
Marfan patients [25]. In other cases re-approximation of the aortic layers and 
restoration of the sinotubular junction with or without aortic valve resuspension can 
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be effective even in presence of severe aortic regurgitation [12,13,24]. Other 
experiences were discordant reporting that the presence of severe aortic 
regurgitation [26] and resuspension of the valve [27] during acute repair are 
significant risk factors for recurrence of severe aortic insufficiency necessitating a 
reoperation. In our experience, the need for proximal redo procedures was related 
to a less radical proximal treatment in patients with flap dissection involving the 
aortic root; we have to conclude that in about 50% of these patients reoperation was 
due to a pathological evolution of the aortic root.
An enlarged or destroyed aortic root [5,24] associated with or without annular 
dilatation [4] should lead surgeons to a more aggressive strategy [24]. Replacement 
of the aortic root with composite conduits has been progressively and increasingly 
performed in the acute setting with an acceptable in-hospital mortality and durability 
[5]. Particularly bioprosthetic root replacement is becoming popular because of a 
encouraging intermediate outcome and the avoidance of life-long anticoagulation 
therapy [25]. Furthermore, recent experiences have shown the feasibility of valve-
sparing root repair in acute dissection [18,28], More extensive root surgery certainly 
has shown to result in a lower rate of reoperation [5,26] but is not immune to late 
and harmful complications, as we registered in our patients 3 cases of proximal redo 
procedure because of endocarditis, false aneurysm and recurrence of aortic 
regurgitation after David reimplantation. 
Distal repair and reoperations 
Some authors have proposed a more aggressive approach with routine total arch 
replacement even with insertion of an elephant trunk or a stented graft in the 
descending thoracic aorta as primary strategy in acute dissection repair [16,17,29]. 
The rationale for this extended treatment is to exclude the dissection completely if 
possible, to promote false lumen thrombosis [17,30], to decrease the risk of the 
development of a postdissection aneurysm of the thoracic and thoracoabdominal 
aorta [7] and the need of a reoperation [6,30]. The reported in-hospital mortality is 
acceptable, ranging from 3.7% to 12.7% [16,17,29], but these papers represent 
excellent results limited by institutional experience and in most of the cases a 
comparable series of less radical procedures was not included. 
A more radical approach is obviously affected by a longer operation, 
cardiopulmonary bypass and cerebral perfusion time [30] and in case of stent 
grafting of the descending thoracic aorta by an increased risk of spinal cord injury 
[31,32]. 
A non resected primary tear and a patent distal false lumen have shown to be risk 
factors for late reoperations and a worse outcome [6,7,14]. In our experience the 
number of patients with an unresected intimal tear is limited, however in these cases 
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there is a tendency of a higher rate of aortic arch replacement during reoperations. 
We observed similar results in case of a dissection flap involving the complete aortic 
arch and/or supra-aortic vessels. Furthermore patients with a dissection extending 
to descending and abdominal aorta had more frequently thoracoabdominal 
reoperations. 
More extensive procedures are extremely fascinating in ‘’freezing’’ the disease 
hoping for a better outcome and a higher freedom from reoperation. We should 
consider that the extensive approach, especially addressing to the descending aorta, 
results in a higher complication risk that should be weighed by the safety of elective 
redo procedures. A longer follow-up is necessary. 
Open distal anastomosis, glues and felts and outcome 
The open distal anastomosis technique has nowadays been fully imbedded in our 
institution during repair of an acute dissection. The main advantage is to prevent 
clamp injuries on a fragile and dissected aorta and furthermore the resection could 
always be extended towards the innominate artery and the aortic arch if necessary. 
Despite these surgical advantages, there are no data supporting a clear long-term 
survival benefit and a decreased need for reoperation by performing an open distal 
anastomosis [3,33,34]. We registered higher occurrence of false aneurysm in 
patients who received distal anastomosis with cross clamping. 
Similarly, the use of glues or predilection for felt reinforcement did not characterize 
the site and the etiology for a reoperation. We are aware of the possibility of aortic 
wall necrosis induced by intraoperative use of GRF or human fibrin glue. However, 
despite our widespread but cautious use of biologic glue, we have reported in a 
previously analyzed cohort of patients who underwent reoperation on the aortic root, 
only 5 cases of aortic false aneurysms over more than 500 aortic root procedures 
[35]. 
Conclusions 
Many papers tried to answer what is the best surgical procedure in acute aortic 
dissection repair. The debate about a less or more radical procedure in the acute 
setting is still open and should not be taken apart from accurate analysis of the early 
and long-term outcome. 
There are three steps that could certainly be assessed. 
The first is the survival after the acute repair. A liberal use of extended surgery could 
minimize the need for a reoperation but this approach is burdened by a higher and 
harmful perioperative complication risk and it is not immune from unpredictable 
evolutions. For this reason, more radical proximal procedures should be reserved in 
severe root involvement or root dilatation. Partial or complete arch replacement 
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should always be considered if a main entry is found distal from the ascending aorta. 
There is no evidence available that extension of the repair into descending aorta 
offers a real benefit. 
The second step is the evolution after repair. We have always recommended a life-
long routine imaging and clinical follow-up to reveal complications and to evaluate 
the growth of the unresected aortic segments. 
The third step is the outcome after reoperation. Our results show that reoperation 
after acute dissection repair could be accomplished safely guaranteeing an 
acceptable long-term prognosis. A redo procedure is not always the mirror of a 
limited repair in the prior operation. 
Since acute aortic dissection will never be studied in a randomized way, these three 
steps should be kept in mind before proposing new paradigms in acute dissection 
treatment. 
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INVITED COMMENTARY 
Aortic dissection is increasingly successfully treated once the patient reaches the 
hospital within a short period of time from the acute event. In almost all cases, 
however, the operation does not completely cure the disease, and the remaining 
dissected aorta is the cause of additional surgical repair and of a reduced long-term 
prognosis. Incomplete resection of the dissected aorta or suboptimal surgical 
strategy is often considered the cause of late complications and the reason for 
reoperation. Increasing the extent of the first operation has been proposed as a way 
of decreasing the number of reoperations but has to be balanced with the increased 
operative surgical risk during the acute phase of the disease. The present article [1], 
coming from one of the leading centers for the treatment of aortic disease, shows 
that even when the first operation is carefully conducted without major changes in 
the standard protocol of simply replacing the ascending aorta, with or without valve 
resuspension and the judicious use of glue, almost 1 of every 5 patients will need a 
reoperation sometime down 
the road. This is already a good piece of information!  
The second finding, somehow expected, is that extension of the disease into the root 
carries a higher risk of proximal reoperation. There are several reasons why an aortic 
root progressively enlarges during the follow-up after a simple supracoronary 
ascending aorta replacement for acute dissection. The root tissues, often partially 
damaged but highly dynamic, because of the presence of a noncompliant Dacron 
(DuPont, Wilmington, DE) graft, are subjected to an increased systolic wall stress 
that leads to progressive enlargement. This process is obviously faster if the root is 
already dilated at the time of dissection. Furthermore, the need for valve 
resuspension or the use of glue simply indicates that the dissection has entered the 
root and, therefore, the aortic layers have lost their integrity, making the root more 
prone not only to dilatation but also to repeat dissection, both conditions often 
associated with secondary valve regurgitation. To simplify a complex problem, we 
could affirm the obvious: the anatomic condition at the time of dissection should 
guide the most appropriate strategy! When the dissection enters the root but is 
limited to the noncoronary sinus, the dissected tissue can be cut out and the sinus 
replaced with minimal additional risk. However, if more than 1 sinus is involved, a 
complete root replacement, whether a classic Bentall or a more complex valve-
sparing procedure, depending on the surgeon’s experience, could be considered. 
Similar to proximal reoperations, the data of the present study clearly indicate how 
a more radical hemiarch procedure should be preferred for a proper and more 
complete treatment. On the one hand, it is now common knowledge that an open 
distal anastomosis, typically associated with antegrade cerebral perfusion, is the 
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crucial step in the surgical strategy to avoid undue problems at the site of the distal 
suture and to reduce the need for late reoperation. On the other hand, at the present 
stage, any unnecessary aggressive treatment of the distal arch or descending aorta, 
or both, does not seem justified and probably, in my opinion, would add an increased 
surgical risk at the time of the acute event. 
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CHAPTER 8 
GENERAL DISCUSSION 
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All the six papers proposed in this thesis provided new insights about reintervention 
on the aortic root and the ascending aorta. Through the read of these studies, 
information about aortic disease and recommendations for the surgical management 
can be retrieved. Chapter 8 provides a systematic presentation of the results, the 
discussion and the review of the literature regarding the outcomes of aortic 
reoperations, the causes for reoperation, the main surgical factor involved in the 
development of aortic complications, the proposed strategies for a safe redo 
procedure and the current role of less-invasive/trans-catheter procedures. 
Populations 
The analysis of homogenous cohort of patients with similar surgical background and 
aortic disease represents the basis to overcome the limitations of previously 
published experiences including patients who received different types of operation 
and presented with different underlying aortic wall pathologies and etiologic factors. 
The proposed studies involved populations with similar aortic disease (Chapters 2 – 
4), a defined target for reoperation (Chapters 5 – 6) and a common pathological 
background (Chapter 7). The results reported in Chapters 2, 5, 6 and 7 derived from 
the analysis of different cohorts retrieved from the global population of patients 
operated at St. Antonius Ziekenhuis. These experiences involved different periods 
of study but shared the most recent years aiming the presentation and the discussion 
of modern outcomes, treatments and surgical strategies. Considering the nature of 
these studies as “single institution experience” based on cohorts of “consecutive 
patients” undergoing aortic surgery, the possibility of an overlap of patients across 
the four different populations should be regarded as expected and unavoidable. 
Chapters 2 and 5 show the highest degree of overlap involving all the sixteen 
patients who received a “true” redo root procedure (main topic of Chapter 5) for the 
treatment of a post surgical Aortic False Aneurysm (main topic of Chapter 2); these 
patients represent the 37% and 35% of the respective populations. We consider this 
finding acceptable for the following four reasons: 
• The methodology of the studies; 
• The relative rarity of diagnosis of aortic false aneurysms and the limited 
occurrence of complications after aortic root replacement requiring a new 
root procedure; 
• The analysis of more recent experiences that were characterized by:  
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1) A widespread and affordable imaging diagnosis and the establishment of 
routine postoperative follow-up; 
2) A progressively consolidated improvement in the management of 
complex surgical scenarios and the treatment of high-risk patients, which 
allows and promotes a more interventional attitude;
• The different aims of the two studies:  
1) Chapter 2 focused on a rare complication following aortic surgery and 
described the possible causes, the anatomical features and the clinical 
presentation of post surgical aortic false aneurysms with a general overview 
of the current strategies for chest re-entry;  
2) Chapter 5 reported the largest available experience at the time of paper 
publication about aortic root reoperations after a previous root procedure and 
highlighted the importance of a proper preoperative assessment and a careful 
intraoperative management in this complex clinical and technical setting. 
A minor overlap exists between the populations examined in Chapter 5 and Chapter 
6 and regards twelve patients who underwent a new composite root replacement 
secondary to homograft (n=10) and pulmonary autograft (n=2) failure.  
Chapter 7 included a large population across four decades of aortic reoperation after 
type A acute aortic dissection repair. In this study we have included only the patients 
who had the primary procedure for dissection performed at St. Antonius Ziekenhuis, 
eight of these cases concurred to form the cohort analysed in Chapter 2 and only one 
of these patients has been included in the population study of Chapter 5. 
Chapters 2 and 4 present the same topic involving two different experiences coming 
from St. Antonius Ziekenhuis (1995-2009) and from Istituto Clinico Humanitas 
(1999-2011) respectively. 
Clinical outcomes 
Re-operations on the proximal thoracic aorta represent a great challenge for 
cardiovascular surgeons. Previous papers reported a mortality rate up to 18% and 
identified several risk factors associated with a poor early outcome: New York Heart 
Association functional class IV, age older than 75 years, chronic obstructive 
pulmonary disease, preoperative and postoperative renal dysfunction, coexisting 
coronary artery disease, CPB time, and urgent operation [1-5]. The interpretation of 
these studies is limited because of the great variability in patients’ selection and the 
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inclusion of any type of redo procedures on the proximal aorta, usually 
independently from the type of the previous cardiac or aortic operation [1-6]. 
We described our experience and analysed “true” re-root procedures and proximal 
reoperations according to different aortic diseases and secondary to the pathological 
evolution of implanted allografts and autografts. The results presented in this thesis 
showed that reoperations on the aortic root and the ascending aorta can be 
accomplished safely. We registered an acceptable early mortality rate, about 5% for 
all the proximal procedures including patients with calcified homografts, aortic false 
aneurysms, infective endocarditis and chronic aortic dissection. Postoperative 
morbidity rate was high. Major complications occurred in 39% to 48% of the 
patients. An early reoperation for excessive bleeding or for tamponade was 
necessary in 9% to 13% of the cases and this could be explained by our attitude of 
not tolerating prolonged bleeding in order to minimize transfusion and to avoid 
hemodynamic imbalance. Perioperative myocardial infarction occurred in about 5% 
of the patients and emerged, with a prior history of coronary artery disease, as a 
negative prognostic factor on early outcome. Pulmonary infection and mediastinitis 
complicated the postoperative course in 10% of the cases. Postoperative sepsis was 
found as an independent risk factor for hospital mortality in patients with aortic false 
aneurysm. The global postoperative cerebral stroke rate was acceptable with less 
than 3% of the patients suffering from a permanent deficit. We registered an early 
and mid-term survival similar to that reported in other large cohort of patients [1,7-
9]; the results are encouraging and underline the efficacy of these procedures.
Causes of reoperation  
Reasons of repeated aortic procedures include the expected deterioration of 
implanted prosthesis, the evolution of aortic disease and unpredictable 
complications such as infection and the development of post surgical aortic false 
aneurysms. We studied the causes of reoperations, their different impact on 
outcomes and their potential relationship with pathologies and surgical strategies at 
the time of the primary operation. 
Surgical techniques 
Technical aspects of the primary operation could affect the durability of the surgical 
aortic repair. Excessive use of glues (GRF or human fibrin glue) has been advocated 
as one of the main cause of aortic complication (i.e. redissection and aortic false 
aneurysm) through a progressive vascular tissue disruption and  aortic wall necrosis; 
however different studies in literatures showed contradictory results [10,11]. Poor 
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anastomotic techniques, the choice of prosthetic graft and anastomotic suture 
materials have been all described in the past as technical factors influencing 
pseudoaneurysm formation. The uses of modern monofilament suture have lessened 
the incidence of false aneurysms development, but, as reported in Chapter 3, we 
faced an unusual spontaneous rupture of a polypropylene suture complicated by a 
proximal aortic pseudoaneurysm in a patient who had a composite root replacement. 
Bioconduit degeneration/complications 
The progressive degeneration or dysfunction of a valve prosthesis account for 
almost one third of the cases of reoperation on the aortic root; these procedures, as 
reported in Chapter 5, are generally burdened by a low operative risk [7,12]. Aortic 
homografts and pulmonary autografts are considered as an ideal substitute for aortic 
replacement in young patients because of their superior hemodynamic performance, 
the absence of anticoagulation treatment and their low infection rate [13-15]. 
However, up to 25% of patients require a reoperation on the implanted homograft 
or pulmonary autograft in 10-15 years period [16-18]. Infection and occurrence of a 
false aneurysm were described in 15%-20% of the patients who underwent a new 
proximal procedure. The dilatation or the development of valve regurgitation have 
been observed as an important disadvantage for the patients, being a reoperation 
considered challenging and high risky [19,20]. In Chapter 6 we reported the results 
of reoperations after homograft and pulmonary autograft implantation. Our study 
confirmed the findings from previous reports [19,21]. Structural valve deterioration 
was the most common cause of reoperation leading to a mixed aortic disease. We 
found that these pathological changes occurred early in patients who received 
homografts from donors more than 55 years old, no significant difference was found 
according to donor-patient age difference. Hospital mortality was 3.8% (2 of 53 
patients) and we registered only one case of postoperative cerebral stroke (1.8%). A 
maximum effort was always taken in managing calcified, fibrotic and frail tissue 
debris. In presence of minor calcifications, it was possible to dissect the flexible wall 
of the homograft and replace the aortic valve in the homograft. In seven cases, we 
faced a completely calcified homograft requiring a redo root replacement with a 
valve-graft conduit to allow an easier implantation with satisfying annular sealing, 
and to prevent potential patient prosthesis mismatch due to valve downsizing. The 
choice for a mechanical or biological prosthesis was made according to the clinical 
presentation and the patient’s profile to ensure adequate prosthesis durability and to 
avoid yet another operation in the future. Based on the average young age of our 
population (50 ± 13 years), a mechanical prosthesis was chosen in most of the cases. 
Autograft replacement with a pulmonary sparing procedure is a recent option for 
patients experiencing a failure of the pulmonary autograft mainly for progressive 
119 
dilatation and in absence of preoperative severe valve dysfunction [22][23]. The 
experiences in repairing the failing pulmonary autograft are still limited but they can 
be performed in selected patients and in presence of normal aortic cusps [22][24].  
Major reoperations on homografts and pulmonary autografts can be performed 
safely with excellent freedom from further aortic valve and root procedures, this 
finding should reassure young patients undergoing homograft implantation or Ross 
procedure. 
Aortic false aneurysm 
Aortic false aneurysm, or pseudoaneurysm, is a rare complication after aortic 
surgery requiring reoperation. Because of a possible silent course and a general lack 
of long-term imaging follow up, it is difficult to state the real incidence of this 
complication, which is roughly estimated around 0.5%-1%. In Chapters 2 and 4 we 
have reviewed the experiences in aortic false aneurysm treatment at St Antonius 
Ziekenhuis and Istituto Clinico Humanitas. Both papers focused on patients’survival 
and reoperation rate but, at the same time, the two chapters explored different 
aspects of this pathological evolution. Chapter 2 treats extensively the technical 
strategies for chest re-entry and the management of vascular tissue; Chapter 4
provides a deeper overview on etiology and documents the cause-effect and 
temporal relationships between infection and the subsequent development of aortic 
false aneurysms. Chapter 3 added a review of all the most significant experiences 
available in literature, as summarized also in Chapter 4 - Table V. A further update 
of case series focusing on conventional surgical and transcatheter treatment of aortic 
false aneurysm is provided in Table 1 and Table 2 in Chapter 8. 
Graft infection and mediastinitis, progressive aortic wall disorder, dissection of the 
native aorta and excessive use of biologic glue are all recognized predisposing 
factors for the development of aortic false aneurysms. Patients with a history of 
aortic dissection or with an infective etiology underwent a reoperation for false 
aneurysm repair after a shorter follow up interval time, furthermore these conditions 
were characterized by a higher operative mortality rate (Chapter 4 and 7). Infection 
is the most threatening condition, because of systemic involvement and the frailty 
of tissues. It has emerged in literature as the main cause of aortic false aneurysm in 
a widely variable number of patients, from 10% to 75%. This great variability 
probably arises from different definitions of infection as a cause: prior postoperative 
febrile status, mediastinitis, endocarditis, positive blood and tissue cultures or septic 
status at reoperation. In Chapter 4 we have described 7 cases of patients who 
presented with infective postsurgical aortic false aneurysm. The diagnosis was 
confirmed by intraoperative findings and supported by preoperative positive blood 
cultures in five patients (with concordant tissue cultures in 2 cases) and a reasonable 
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time correlation between infection and false-aneurysm development and diagnosis. 
Radiological and ultrasound investigation did not detect any aortic false aneurysm 
soon after the appearance of fever and signs of systemic inflammation, thus 
revealing the pathogenic role of infection in the subsequent false aneurysm 
development.  
Aortic graft replacement, as in Chapter 2, was our strategy of choice with 70% of 
the patients receiving an extensive repair and aortic substitution. Atik and coll [9] 
reported similar operative techniques with only 28% of patients undergoing direct 
suture or patch repair of the false aneurysm. Simple repair is not the optimal solution 
also in uninfected patients because of the fragility of the suture line tissue that may 
lead to early complications or recurrence of aortic false aneurysm as described in 
Chapter 4. However, in severely ill patients, closure of the false aneurysm is the 
only proper lifesaving procedure, and it could represent a reasonable technical 
solution in absence of signs of infection and of large pseudoaneurysm neck. 
Aortic dissection: progression of aortic wall disease and complications 
The progression of aortic disease accounts for the majority of reoperations in 
patients who underwent aortic surgery [4][25][26]. The evolution of unresected 
aortic segment in a context of chronic degenerative aneurysm is nowadays well 
prevented by a careful and appropriate surgical technique selection and extension of 
aortic wall resection for the repair of thoracic aorta aneurysms [27] but it is not 
uncommon in patients with bicuspid aortic valve and connective tissue disorders 
[28][29]. A history of aortic dissection and urgent prior operation represent 
significant risk factors for further reoperations especially in patients with aortic wall 
pathologies [30-32]. 
The primary goal in treating patients with acute type A dissection is avoiding aortic 
rupture and cardiac tamponade and to solve dissection related malperfusion 
syndromes. The exclusion of the intimal tear with the resection of the ascending 
aorta and the reapproximation of the aortic layers are the cornerstone of the surgical 
repair. This strategy is associated with an acceptable mortality rate but certainly 
leaves many patients at risk for future reoperations. Several mechanisms of 
pathological evolution such as progressive aortic valve regurgitation, progressive 
dilatation of a preserved aortic root and of non-resected distal segments of the native 
aorta, and the occurrence of unpredictable complications (infection and false 
aneurysms) could give rise to reoperations. A more extensive surgical repair seems 
to be protective in preventing future reoperations, however it could be burdened by 
a higher mortality and morbidity rate [33,34]. The debate about the suitability and 
effectiveness of less or more radical procedures in the acute setting is still open. In 
Chapter 7 we reviewed our experience in reoperation after acute dissection repair. 
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We investigated the causes for reoperations, the surgical indication, the timing of 
redo surgery and the involvement of specific aortic segments. The overall mortality 
was 7.7%, particularly it was higher in presence of aortic false aneurysms or 
infection (25% vs. 3.6% in the remaining cases). Our results showed that reoperation 
after acute dissection repair could be accomplished safely guaranteeing an 
acceptable long-term prognosis.  
In our experience, the need for proximal redo procedures was related to a less radical 
proximal treatment in patients with intima dissection involving the aortic root; in 
many cases conservative aortic root repair had demonstrated acceptable long-term 
clinical outcomes even in presence of severe aortic regurgitation [35-38]. 
Several risk factors for proximal aortic reoperation have been described in patients
who underwent dissection repair with aortic wall resection and replacement limited 
to the supracoronary aorta: 
• Demographic: Marfan syndrome; young age (<40/<60 years old); 
• Anatomic: Aortic annulus diameter>27 mm [39]; 
• Technical: use of biological Glues; aortic valve resuspension [40]; 
• Functional: Aortic regurgitation degree moderate to severe [41-43]; Cardiac 
malperfusion [33]; 
• Pathologic: Dissection of all 3 sinuses of Valsalva [44][45]. 
These findings came from retrospective studies not always including data and details 
about the preoperative anatomy of the aorta, the extension of the dissection and the 
degree of involvement of the aortic root. For this reason, apart from the evidence of 
underlying connective tissue disorders, they should not be considered absolute 
indications able to characterize clinical and anatomic scenarios that require always 
a more extensive proximal repair. 
Marfan syndrome emerged in several experiences as a strong predisposing factor at 
medium term for pronounced aneurysmatic evolution or development of new aortic 
complication in a retained dissected or dilated aortic root with a rate of proximal 
reoperation up to 50% at 10 years [46]. Similarly, young patients experienced a 
higher rate of proximal reoperation. This finding is not simply related to a longer 
survival expectancy, a prolonged exposition to aortic complication or an easier 
acceptance for a redo procedure. Patients <40 years old, operated on for type A 
aortic dissection, show usually a more dilated proximal aorta and aortic annulus and 
vascular anatomic features similar to Marfan patients [47]. Alongside the well-
characterized syndromic disorders, there are increasing evidences describing the 
role of further genetic mutations determining alterations of structural and metabolic 
aortic wall properties and leading to higher risk of development of thoracic aortic 
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aneurysm and related complications at a younger age. These patients represent up 
to 20% of all thoracic aortic aneurysm cases. They do not have any evident 
syndromic feature and could show a familial inheritance (non-syndromic familial 
thoracic aortic aneurysm) or present as isolated case of aortic disease in very young 
age. 
The presence of an enlarged aortic annulus diameter (>27 mm) is extensively 
proposed in literature as a risk factor for reoperation, thus justifying a more 
aggressive attitude towards the replacement of the aortic root. The presence of pre-
existing aortic abnormalities can sustain a faster root dilatation or development of 
aortic valve regurgitation. It is however debatable to consider this value as an 
absolute cut-off since it is coming from a very small subgroup of patients (four 
patients reoperated of 8 with aortic annulus>27mm) in a large population of patients 
with dissected root who underwent supracoronary aorta replacement [39]. 
A more pronounced root involvement intuitively may support a pronounced 
progression of the aortic pathology. The dissection of all aortic sinuses [45] or its 
extension into the coronary ostia, seem to predict a high risk for reoperation; 
similarly, patients with preoperative cardiac malperfusion, seen as a marker of 
severity of destruction of the root, experience a higher rate of proximal aorta redo 
procedures during the follow up [33]. The presence of preoperative moderate to 
severe aortic regurgitation degree has been found as an independent risk factor for 
proximal reoperation at mid-term [41-43]. The extension of the dissection flap into 
the Valsalva Sinuses causes the loss of annular support and leaflets(s) prolapse. 
Despite patients with leaflets prolapse have significantly greater degree of aortic 
annulus dissection, the presence of the prolapse itself is enough to justify a severe 
aortic valve regurgitation even when related to a limited proximal dissection [48]. 
Furthermore, significant valve dysfunction may be consequence of leaflet(s) 
tethering secondary to sinotubular junction dilatation or of malcoaptation due to 
diastolic impingement of the dissection flap into the aortic orifice. In absence of 
clear evidence and description of the mechanism leading to aortic insufficiency, the 
degree of regurgitation should not be considered an absolute marker of a more 
extensive proximal disease. The mechanism of the regurgitation and a complete 
description of anatomical and functional alterations of the aortic root are more 
important than the mere regurgitation degree in suggesting a surgical strategy in 
proximal repair.  
Some consensus exists that an enlarged or destroyed aortic root [36,43], with or 
without annular dilatation [39], and Marfan syndrome [49,50] should lead surgeons 
to a more aggressive strategy [36].  
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More extensive root surgery certainly has shown to result in a lower rate of 
reoperation [41,49] but is not immune to late and harmful complications that are 
burdened by higher postoperative mortality.  
When analysing these results we should of course consider patients who disappeared 
from survival tables because of sudden and not better specified death, patients who 
may require and benefit from redo surgery during follow-up and those not scheduled 
or amenable for further aortic procedures. The acute repair should be guided by the 
maximum effort in achieving patients’ survival keeping in mind that a possible redo 
procedure could be feasible and safe. A reoperation in patients who survived acute 
type A aortic dissection is not always the mirror of something wrong in the setting 
of acute repair, on the contrary in most of the cases a redo operation represents an 
opportunity which could guarantee a better outcome and longer survival. 
Technical aspects 
Each step of the reoperation should be assessed and properly prepared to decrease 
the incidence of severe problems.  
Resternotomy and chest re-entry 
Chest re-entry is the first crucial moment of the redo procedure especially in 
presence of cardiovascular structures beneath the posterior aspect of the sternum 
that pose the risk of damage of vital structures such as the right ventricle, the 
pulmonary artery, the aorta or by-pass grafts. Injuries during chest re-entry occur in 
up to 7%-9% of the cases [51][52] and mostly during resternotomy or during tissue 
dissection before the establishment of CPB. A complicated re-entry is associated 
with a significant increase in early mortality especially when injury occurs during 
sternal division and involved the aorta, the right ventricle or the coronary sinus 
[51][53]. Preventive strategies such as avoiding, when feasible, median sternotomy, 
the exposure of peripheral vessels for a prompt CPB institution, the establishment 
of cardiopulmonary bypass before chest re-entry, minimize the risk of mediastinal 
structures damage and allow a rescue tool to support the haemodynamic imbalance 
secondary to important bleeding or heart ischaemia [54]. These measures are 
however not always effective in preventing an injury at the re-entry but the 
possibility to counteract such a catastrophic and emergency situation could 
guarantee a better outcome and higher chances of survival [52]. An adequate 
preoperative CT scan imaging is mandatory in every patient to delineate the 
relationship between cardiac and vascular structures and the sternum and has a 
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strong association with the adoption of preventive surgical strategies in patients 
undergoing redo cardiac surgery [52][54]. The CT findings can guide the choice of 
re-entry site, suggest scenarios with a high risk of cardiovascular structures damage, 
and provide details of spatial arrangements of previously implanted coronary artery 
bypass grafts thus reducing manipulation and tissue dissection [55]. 
The management of resternotomy in case of mediastinal aortic false aneurysm is 
paradigmatic of a successful strategy for a safe re-entry in aortic reoperation. Our 
policy is to reserve peripheral cardiopulmonary bypass institution before re-entry 
only in the presence of less than 2 cm of space between mediastinal structures and 
the sternum. This strategy resulted in re-entry complications in 5 patients. In three 
patients, this possibility was judged as highly probable and patients were already on 
CPB or in deep hypothermic circulatory arrest. Settepani and coworkers [56] and 
Katsumata and associates [57] suggested to start CPB followed by cooling the 
patient down to 16° to 18°C or 22°C in case of less than 2 cm of space under the 
sternum and just to 28°C if the false aneurysm appeared to have no relation with the 
sternum [56]. Mohammadi and colleagues [5] reported their strategy as the 
preference to cannulate the two carotid arteries separately to avoid brain 
hypoperfusion and air embolism in case of high risk of false aneurysm rupture. A 
similar proposal for brain protection was reported by Bachet and associates [58]. In 
every case, the decision about managing chest re-entry was taken after a careful 
evaluation of the risk of false aneurysm rupture. 
Myocardial protection and re-establishment of coronary flow 
Cardiac protection is fundamental for carrying out a safe procedure. Left ventricular 
distension during ventricular fibrillation while cooling down the patient, inadequate 
protection during ischemic diastolic cardiac arrest and suboptimal coronary flow re-
establishment may lead to myocardial damage, necrosis or stunning, and post-
operative complications. 
We usually administered cold crystalloid cardioplegia into the coronary ostia and 
repeated the dose when the ventricular septal temperature exceeded 10°C. 
Continuous topical cooling was used during cardiac arrest and the left ventricle was 
vented by insertion of a cannula in the right upper pulmonary vein. As reported in 
Chapter 5, we registered an acceptable rate of perioperative myocardial infarction 
considering that they were all “true” re-root procedures and the intrinsic difficulties 
in handling calcified or infective tissue. A strategy with a single-dose cardioplegia 
providing 2-3 hours of myocardial preservation might be helpful and seems to 
protect the heart better during a longer cross-clamp time [59]. Furthermore, 
normothermic cardioplegia is not applicable in these complex aortic procedures, 
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since deep hypothermic circulatory arrest or mild-to-moderate hypothermia is often 
required. 
The management of coronary flow reestablishment is still demanding. In previous 
experiences failure of coronary reimplantation was reported in 25% to 50% of the 
cases, leading to intraoperative and postoperative coronary malperfusion resulting 
in a higher early mortality rate, about 70% in the report from Kirsch and coll. [1]. 
We were able to re-establish physiological coronary flow in most of the cases (93%), 
this probably concurred to a low rate of perioperative myocardial infarction and, 
since perioperative myocardial ischaemia was found as a significant risk factor for 
early death, in-hospital mortality. 
Isolation of cardiac and vascular structures 
Preparation of the aortic root in a reoperation is a challenging and precise job, 
alongside the coronary ostia, the pulmonary trunk and the right pulmonary artery 
could be injured and in this case the problem should be immediately recognized and 
properly actions taken for a successful repair. This technically demanding 
management is more difficult in case of homograft degeneration, especially in the 
presence of complete calcified valve and vascular wall, and of infective disease 
which requires always an extensive debridement and the excision of all necrotic and 
infected tissue to avoid the recurrence of prosthetic infection or occurrence of sepsis 
and mediastinitis. 
Conservative management and transcatheter procedures 
The natural history of aortic false aneurysm is still not well defined, so the diagnosis 
of these lesions, regardless of their size, has been considered an indication for 
surgical repair. In Chapter 4 we reported the outcomes of 4 patients, all 
asymptomatic, who did not undergo reoperation after the diagnosis of aortic false 
aneurysm. The follow-up time presented is relatively short, and only 2 patients 
agreed to further imaging evaluations. In the first, during a 37-month period, we 
found almost unchanged diameters of a false aneurysm arising from the proximal 
suture line of a composite valve graft; in the second patient, routine CT scan 
revealed an 8-mm increase in a false aneurysm arising from the left coronary ostium. 
These findings could suggest a conservative approach in asymptomatic patients with 
a small aortic false aneurysm; however, the evolution of the lesion is unpredictable 
and late rupture or related sequelae could convey the patient to an emergent 
operation with unacceptable operative risk. In addition to symptomatic patients in 
whom reoperation should not be delayed, all asymptomatic patients diagnosed with 
aortic false aneurysm should be informed of the possible life-threatening evolution, 
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and surgical options should be discussed with those in whom surgery would be 
appropriate. 
The possibility to avoid an open surgical procedure is attractive especially in 
patients presenting with critical preoperative status. In recent years percutaneous 
stent graft placement, device occluder implantation and coil embolization have been 
proposed for the treatment of a false aneurysm of the thoracic aorta [60,61]. Small 
series of endovascular repair of the ascending aorta were reported in literature. They 
were limited to the treatment of very high risk patients and accounted for a 
significant mortality and intraprocedural complication rates [62,63]. Endovascular 
techniques have some limitations depending on the location of the false aneurysm 
and the size of the communication tear. Stent grafts need an adequate landing zone 
and may not be a safe option in proximity of coronary ostia and supra-aortic vessels. 
The lack of specific designed systems, the need of alternative nonfemoral 
approaches to adapt the use of current technology (e.g delivery systems often too 
short to reach the ascending aorta, difficult passage through the aortic arch 
curvature) and of CPB support in patients with unstable haemodynamic, represent 
further challenges for the endovascular repair of lesions in the ascending aorta. Coil 
embolization could be effective in small false aneurysm with narrow neck, however 
report of these procedures are anecdotal [64]. Occluder devices may have a more 
extensive use but the absence of firm tissue, especially in infective lesions, increases 
the risk of device migration and embolization and the possibility of residual leak. 
The results reported in small case series and case reports are inconsistent with a 
cumulative intraprocedural success rate of about 86% (12/14 patients) [61]. This 
finding does not include postoperative complications as persistent flow within the 
false aneurysm cavity or device dislodgment. Furthermore, follow-up data is 
limited. The effectiveness and safety of transcatheter procedures are still far from 
being optimal. Our results report an in-hospital mortality rate of 6.9%, a survival at 
1, 5 and 10 years of 94%, 79% and 68% respectively, and a freedom from 
reoperation of 86% and 72% at 1 year and 10 years We demonstrated, with regards 
to the complex subject of reoperation for aortic pseudoaneurysms after prior cardiac 
operations, that open surgical repair remains the most prudent and successful 
approach. 
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Conclusions 
Several findings can be retrieved from our experiences in reoperations of the 
proximal aorta. We depicted a complete review of the possible causes leading to 
redo aortic surgery, and provided a new and modern outlook of the outcomes of 
patients undergoing these complex and invasive procedures. We demonstrated that 
reoperative surgery could be accomplished safely and with acceptable postoperative 
morbidity and durable results. These evidences are not merely descriptive and 
should have a critical repercussion in the evaluation of the prognostic operative 
ground of redo procedures, and in the surgical strategy for primary aortic operations 
regarding the choice of valve substitutes and the extension of aortic repair. 
Furthermore, we proposed and discussed our technical and practical strategies 
derived from the most advanced cardiovascular surgical techniques and allowing 
the best myocardial, cerebral and visceral protection. A systematic approach with a 
regular follow up, a prompt surgical indication and a complete and proper 
preoperative assessment, translate in the best possible outcome in these challenging 
scenarios. 
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Table 2. Case series of percutaneous treatment for aortic false aneurysm (FA) 
Study N Age Prior Surgery Follow-up
      
Bashir
2005
[71]
1 63 MV repair + CABG   1 month
Kanani
2007
[72]
3 78
68
51
No surgery
CABG
CABG
  1 month
  2 months
None
Jolly
2007
[73]
1 95 - Device embolization
Increased FA size at 2 months
Kannan
2009
[74]
2 60
63
12 months
  3 months
Hussain
2009
[60]
6 58
79
78
60
75
81
Asc aorta replacement
No surgery
ATAAD repair
Arch and DTA replacement
MVR
-
11 months: recurrence of FA
None
Intraoperative death
None
None
Failure of device implantation
Scholtz
2010
[75]
1 74 CABG+AVR   3 months
Kumar
2012
[76]
3 59
59
71
ARR+CABG; FA repair
ARR+CABG
ATAAD repair
-
-
  2 months
ARR: aortic root replacement; ATAAD: acute type A aortic dissection; AVR: aortic 
valve replacement; CABG: coronary artery bypass grafting; DTA: descending 
thoracic aorta; MVR: mitral valve replacement. 
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CHAPTER 9 
SUMMARY 
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Part 1 – Post surgical Aortic False Aneurysm (Chapters 2 – 4) 
Chapter 2: Aortic false aneurysm can present even after several years from the first 
aortic operation and in more than half of the cases they can have an asymptomatic 
course. Because of their unpredictable evolution they represent however a life-
threatening condition. Dissection of the native aorta, underlying connective tissue 
disorders and perioperative infection are well recognized risk factors for the 
development of aortic false aneurysms, and they were common in our population. 
Patients with at least one of these risk factors presented early for a reoperation, 
especially in case of infective disease. The management of chest re-entry in case of 
a mediastinal aortic false aneurysm is paradigmatic of a successful strategy for a 
safe resternotomy in aortic reoperation. Our policy provided CPB institution before 
resternotomy in presence of less than 2 cm space between mediastinal structures and 
the sternum. We experienced re-entry complications in 5 patients and no 
intraoperative death. The in-hospital mortality rate was acceptable despite the high 
rate of postoperative complications. The long-term outcome was satisfactory, 
similarly the freedom from further reoperations which benefited from our strategy 
of extensive aortic resection and graft replacement in the redo setting. 
Chapter 3: Technical factors may have a role in the etiology of post surgical 
pseudoaneurysms but mechanisms and incidence are not clarified; there are 
discordant evidences about disruption of vascular tissue caused by an excessive use 
of biological glues, furthermore, the evaluation of the impact of anastomosis 
techniques is even more difficultly objectified. Despite the uses of modern 
monofilament suture have lessened the incidence of pseudoaneurysm formation, we 
faced an unusual case of false aneurysm due to an anomalous spontaneous rupture 
of the proximal anastomosis suture following a valve graft replacement of the aortic 
root. 
Chapter 4: Infection is recognized as one of the main etiologic factor in the 
occurrence of post surgical aortic false aneurysm. Previously, it was reported to be 
the main cause in a widely variable number of patients. Different definitions of 
infection as a cause account for this finding. We demonstred the role of infection in 
false aneurysm development considering the intraoperative findings, the presence 
of positive preoperative blood cultures, the results of tissue cultures, and the time 
correlation between history of mediastinitis, endocarditis, or sepsis and false-
aneurysm diagnosis. We suggested that routine monitoring should be carried in all 
patients who have undergone aortic surgery and presented signs of infections in the 
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early postoperative period, or had recurrent or persistent signs of active 
inflammation. 
Part 2 – Reoperations on the Aortic Root (Chapters 5 – 6) 
Chapter 5: Although a first-time operation on the aortic root is performed routinely 
with low operative risk, an operative mortality rate of up to 18% for “true” redo root 
procedure was common in literature. We reported acceptable early and long-term 
results despite the high rate of emergency operations and the evidence of vascular 
graft or valve prosthetis infection in more than one third of our patients. 
Perioperative myocardial ischaemia emerged as the only risk factor for in-hospital 
mortality. This finding underlined the importance of myocardial protection during 
all the phases of the operation. Left ventricular distension during ventricular 
fibrillation and inadequate protection during ischemic diastolic cardiac arrest may 
generally lead to myocardial damage. Another important factor in redo root 
procedures is the correct re-establishement of the coronary flow. Previous 
experiences reported a failure in coronary ostia reimplantation in 25% to 50% of the 
cases. We were forced to a graft elongation to the coronary arteries and an urgent 
intraoperative coronary artery bypass graft to the right coronary artery in only two 
patients. The satisfactory management of native coronary flow accounted for our 
encouraging results in these difficult settings. 
  
Chapter 6: Reoperations after homograft implantation were mainly due to the 
development of structural valve deterioration with an early presentation in patients 
who received a homograft from a donor aged over 55 years old. Pulmonary autograft 
failure was characterized by valve leaflets prolapse or dilatation of the autograft. 
The in-hospital mortality rate was acceptable despite a complicated postoperative 
course in almost half of the patiens. The patients who received a prior pulmonary 
autograft had no in-hospital mortality after the reoperation. Our experience showed 
that, even in presence of severe and diffuse calcified degeneration, a proximal 
reoperation could be accomplished safely and with low risk of myocardial and 
cerebral damage. 
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Part 3 – Reoperations after dissection repair (Chapters 7) 
Chapter 7: Patients who underwent a successful repair of acute type A aortic 
dissection may require aortic reoperations due to the evolution of aortic disease, the 
enlargement of unresected aortic segments, the development of aortic regurgitation 
or because of complications such as infective endocarditis or occurrence of false 
aneurysm. A severe involvement of the aortic root represents a risk factor for a 
proximal redo procedure even in absence of significant aortic regurgitation at the 
time of dissection. The presence of an unresected intimal tear in the arch may 
predispose to a distal reoperation. These findings may support the systematic 
adoption of more radical procedures during the acute setting aiming a reduced risk 
of further aortic operations. We reported, however, an acceptable mortality rate and 
stated the possibility to perform a safe redo procedure. Furthermore, a radical 
proximal or distal repair is not immune from life-threatening complication (i.e. 
coronary ostia false aneurysm). These findings should be always taken into account 
while proposing and offering in the acute setting more extensive and possible higher 
risk procedures, a tailored approach addressing and respecting patients’ 
characteristics and the clinical presentation, is requested to guarantee the best 
outcome and freedom from reoperation. 
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